| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 1.26e-11 | 38 | 231 | 10 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MYO7B MYO9A KIF5B DNAH9 DYNC2H1 MYH14 | 1.13e-09 | 118 | 231 | 13 | GO:0003774 |
| GeneOntologyMolecularFunction | actin filament binding | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MYO7B MYO9A SPTAN1 SPTBN1 CAMSAP3 LCP1 GSN FMNL3 MYH14 CLMN | 1.32e-09 | 227 | 231 | 17 | GO:0051015 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MAP2 SPTAN1 SPTBN1 ASPM CAMSAP3 MYH14 TJP1 CDK5RAP2 UNC13A | 1.18e-08 | 230 | 231 | 16 | GO:0005516 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | EPS8 MYH2 MAP9 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MAP2 MYO7B MYO9A SPTAN1 SPTBN1 KATNAL1 TUBGCP5 CLIP1 NF2 SYNE2 KIF5B DNM1 TRIM36 MTUS2 DCTN2 CAMSAP3 ANKRD23 LCP1 GSN FMNL3 MYH14 CLMN PHACTR4 IRAG2 CDK5RAP2 UNC13A EP300 | 1.52e-08 | 1099 | 231 | 36 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | EPS8 MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MAP2 MYO7B MYO9A SPTAN1 SPTBN1 NF2 SYNE2 CAMSAP3 LCP1 GSN FMNL3 MYH14 CLMN PHACTR4 | 4.38e-08 | 479 | 231 | 22 | GO:0003779 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP5F1E MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 ABCF3 ATRX MYO7B MYO9A DHX38 MCM3 KATNAL1 KIF5B DHX29 DNAH9 ATP5F1EP2 ATG7 DYNC2H1 TRAP1 MYH14 MCM9 CDC6 | 5.31e-08 | 614 | 231 | 25 | GO:0140657 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 2.37e-07 | 13 | 231 | 5 | GO:0016713 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.50e-05 | 5 | 231 | 3 | GO:0052871 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP5F1E MYH3 MYH4 MYH7 ABCF3 PLPP5 ATRX DHX38 MCM3 KATNAL1 NUDT12 GNL2 KIF5B DNM1 DHX29 DNAH9 ATP5F1EP2 DYNC2H1 MFN1 RND3 ARHGAP5 TRAP1 MCM9 CDC6 REM2 | 1.51e-05 | 839 | 231 | 25 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP5F1E MYH3 MYH4 MYH7 ABCF3 PLPP5 ATRX DHX38 MCM3 KATNAL1 NUDT12 GNL2 KIF5B DNM1 DHX29 DNAH9 ATP5F1EP2 DYNC2H1 MFN1 RND3 ARHGAP5 TRAP1 MCM9 CDC6 REM2 | 1.54e-05 | 840 | 231 | 25 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP5F1E MYH3 MYH4 MYH7 ABCF3 PLPP5 ATRX DHX38 MCM3 KATNAL1 NUDT12 GNL2 KIF5B DNM1 DHX29 DNAH9 ATP5F1EP2 DYNC2H1 MFN1 RND3 ARHGAP5 TRAP1 MCM9 CDC6 REM2 | 1.54e-05 | 840 | 231 | 25 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP5F1E MYH3 MYH4 MYH7 ABCF3 ATRX DHX38 MCM3 KATNAL1 KIF5B DHX29 DNAH9 ATP5F1EP2 DYNC2H1 TRAP1 MCM9 CDC6 | 1.61e-05 | 441 | 231 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP5F1E MYH3 MYH4 MYH7 ABCF3 ATRX DHX38 MCM3 KATNAL1 GNL2 KIF5B DNM1 DHX29 DNAH9 ATP5F1EP2 DYNC2H1 MFN1 RND3 ARHGAP5 TRAP1 MCM9 CDC6 REM2 | 3.59e-05 | 775 | 231 | 23 | GO:0017111 |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 5.17e-05 | 7 | 231 | 3 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 5.17e-05 | 7 | 231 | 3 | GO:0018685 | |
| GeneOntologyMolecularFunction | phospholipid binding | CPNE2 ARHGAP26 SPTBN1 ADGRB1 MYCBPAP TPCN1 SH3YL1 FCHSD2 DNM1 CAVIN2 ARAP2 ANKFY1 APOA4 APOB CPS1 GSN UNC13A CPNE7 | 7.38e-05 | 548 | 231 | 18 | GO:0005543 |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 1.33e-04 | 2 | 231 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 1.33e-04 | 2 | 231 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 1.33e-04 | 2 | 231 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 1.33e-04 | 2 | 231 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.73e-04 | 10 | 231 | 3 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.73e-04 | 10 | 231 | 3 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.73e-04 | 10 | 231 | 3 | GO:0102033 | |
| GeneOntologyMolecularFunction | spectrin binding | 6.16e-04 | 34 | 231 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | microtubule binding | MAP9 MAP2 KATNAL1 TUBGCP5 CLIP1 KIF5B DNM1 MTUS2 CAMSAP3 IRAG2 CDK5RAP2 | 9.64e-04 | 308 | 231 | 11 | GO:0008017 |
| GeneOntologyMolecularFunction | lipid binding | CPNE2 CYP4F8 CYP11B1 CYP11B2 ARHGAP26 SPTBN1 ADGRB1 MYCBPAP TPCN1 SH3YL1 FCHSD2 DNM1 CAVIN2 ARAP2 ANKFY1 UGT1A9 CYP4F2 APOA4 APOB CPS1 GSN UNC13A CPNE7 | 1.16e-03 | 988 | 231 | 23 | GO:0008289 |
| GeneOntologyMolecularFunction | 3-hydroxyacyl-CoA dehydrogenase activity | 1.94e-03 | 6 | 231 | 2 | GO:0003857 | |
| GeneOntologyMolecularFunction | double-stranded RNA adenosine deaminase activity | 1.94e-03 | 6 | 231 | 2 | GO:0003726 | |
| GeneOntologyMolecularFunction | cadherin binding | ABCF3 RSL1D1 SPTAN1 SPTBN1 TRIM29 STX5 KIF5B DHX29 RTN4 SLC3A2 TJP1 | 2.06e-03 | 339 | 231 | 11 | GO:0045296 |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 2.11e-03 | 78 | 231 | 5 | GO:0003725 | |
| GeneOntologyBiologicalProcess | actin filament-based process | EPS8 MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MYO7B ARHGAP26 SPTAN1 SPTBN1 ADGRB1 FCHSD2 NF2 AMOT SYNE2 PCDH15 KRT8 PDCD6IP ANKRD23 LCP1 GSN FMNL3 RND3 MYH14 TJP1 PHACTR4 EP300 | 3.53e-07 | 912 | 229 | 29 | GO:0030029 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 4.43e-07 | 15 | 229 | 5 | GO:0030049 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | EPS8 MYH3 MYH6 MYH7 MYH10 MYH11 MAP2 MYO7B SPTAN1 SPTBN1 KATNAL1 TUBGCP5 CLIP1 FCHSD2 NF2 KRT71 PCDH15 KRT3 KRT7 KRT8 CAMSAP3 ANKRD23 LCP1 P3H4 GSN RND3 TJP1 CDK5RAP2 EP300 | 9.42e-07 | 957 | 229 | 29 | GO:0097435 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | EPS8 MYH3 MYH6 MYH7 MYH10 MYH11 MYO7B ARHGAP26 SPTAN1 SPTBN1 ADGRB1 FCHSD2 NF2 AMOT PCDH15 KRT8 PDCD6IP ANKRD23 LCP1 GSN FMNL3 RND3 MYH14 TJP1 PHACTR4 EP300 | 1.07e-06 | 803 | 229 | 26 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 1.23e-06 | 18 | 229 | 5 | GO:0033275 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 5.15e-06 | 86 | 229 | 8 | GO:0030239 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MAP9 MYH3 MYH6 MYH7 MYH10 MYH11 STAG1 TUBGCP5 ASPM DHX29 KRT8 PDCD6IP ANKRD23 LCP1 GSN CDK5RAP2 RPL5 EP300 | 6.53e-06 | 475 | 229 | 18 | GO:0140694 |
| GeneOntologyBiologicalProcess | striated muscle cell development | 6.66e-06 | 89 | 229 | 8 | GO:0055002 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 8.40e-06 | 153 | 229 | 10 | GO:0030048 | |
| GeneOntologyBiologicalProcess | organelle assembly | MAP9 MYH3 MYH6 MYH7 MYH10 MYH11 STAG1 SPEF2 TUBGCP5 FSIP2 NF2 SYNE2 ASPM PCDH15 DHX29 KRT8 PDCD6IP ATG7 DYNC2H1 CNTRL ANKRD23 LCP1 GSN CDK5RAP2 CFAP74 ATM CFAP61 ULK2 RPL5 EP300 | 9.86e-06 | 1138 | 229 | 30 | GO:0070925 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | MYH3 MYH6 MYH7 MYH10 MYH11 NF2 KRT8 PDCD6IP ANKRD23 MYH14 TJP1 EP300 | 1.57e-05 | 239 | 229 | 12 | GO:0031032 |
| GeneOntologyBiologicalProcess | post-embryonic development | 2.04e-05 | 135 | 229 | 9 | GO:0009791 | |
| GeneOntologyBiologicalProcess | endosomal vesicle fusion | 2.43e-05 | 16 | 229 | 4 | GO:0034058 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 2.64e-05 | 6 | 229 | 3 | GO:0036101 | |
| GeneOntologyBiologicalProcess | adult heart development | 4.01e-05 | 18 | 229 | 4 | GO:0007512 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 4.57e-05 | 7 | 229 | 3 | GO:0036102 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 4.84e-05 | 59 | 229 | 6 | GO:0045214 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 7.26e-05 | 8 | 229 | 3 | GO:0036100 | |
| GeneOntologyBiologicalProcess | membrane organization | STX2 MYH2 MYH10 SAMD9 SPTBN1 VPS33A ADGRB1 CLIP1 FCHSD2 STX5 KIF5B DNM1 IMMT CAVIN2 DOCK1 ANKFY1 PDCD6IP ATG7 VPS39 RTN4 TMEM43 GSN IRAG2 SLC25A31 | 8.65e-05 | 914 | 229 | 24 | GO:0061024 |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell-granule cell precursor cell signaling | 1.23e-04 | 2 | 229 | 2 | GO:0021937 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MAP9 STAG1 ATRX MAP2 SPEF2 KATNAL1 TUBGCP5 CLIP1 LYST FSIP2 SYNE2 ASPM KIF5B TRIM36 DNAH9 FLOT2 PDCD6IP DYNC2H1 DCTN2 CNTRL CAMSAP3 APOB MEI1 CDK5RAP2 CFAP74 CFAP61 | 1.27e-04 | 1058 | 229 | 26 | GO:0007017 |
| GeneOntologyBiologicalProcess | cortisol biosynthetic process | 1.53e-04 | 10 | 229 | 3 | GO:0034651 | |
| GeneOntologyBiologicalProcess | tertiary alcohol biosynthetic process | 1.53e-04 | 10 | 229 | 3 | GO:1902645 | |
| GeneOntologyBiologicalProcess | vesicle fusion | 1.91e-04 | 142 | 229 | 8 | GO:0006906 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 2.09e-04 | 11 | 229 | 3 | GO:1901523 | |
| GeneOntologyBiologicalProcess | aldosterone biosynthetic process | 2.09e-04 | 11 | 229 | 3 | GO:0032342 | |
| GeneOntologyBiologicalProcess | organelle membrane fusion | 2.11e-04 | 144 | 229 | 8 | GO:0090174 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 2.21e-04 | 145 | 229 | 8 | GO:0001578 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | EPS8 MAP9 MAP2 SPTAN1 SPTBN1 CLIP1 FCHSD2 NF2 TRIM36 PDCD6IP CAMSAP3 ANKRD23 GSN RND3 TJP1 CDK5RAP2 EP300 | 2.72e-04 | 579 | 229 | 17 | GO:0051493 |
| GeneOntologyBiologicalProcess | cortisol metabolic process | 2.76e-04 | 12 | 229 | 3 | GO:0034650 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 2.76e-04 | 12 | 229 | 3 | GO:0042758 | |
| GeneOntologyBiologicalProcess | organelle fusion | 2.83e-04 | 190 | 229 | 9 | GO:0048284 | |
| GeneOntologyBiologicalProcess | mineralocorticoid biosynthetic process | 3.56e-04 | 13 | 229 | 3 | GO:0006705 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 3.62e-04 | 156 | 229 | 8 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 3.62e-04 | 156 | 229 | 8 | GO:0010927 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | EPS8 MAP2 SPTAN1 SPTBN1 VPS33A CLIP1 FCHSD2 VPS39 CAMSAP3 LCP1 GSN CDK5RAP2 ATM UNC13A EP300 | 3.95e-04 | 489 | 229 | 15 | GO:0043254 |
| GeneOntologyBiologicalProcess | primary alcohol biosynthetic process | 4.49e-04 | 14 | 229 | 3 | GO:0034309 | |
| GeneOntologyBiologicalProcess | aldosterone metabolic process | 4.49e-04 | 14 | 229 | 3 | GO:0032341 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP9 STAG1 ATRX MAP2 SPEF2 KATNAL1 TUBGCP5 CLIP1 FSIP2 SYNE2 ASPM TRIM36 PDCD6IP DCTN2 CNTRL CAMSAP3 MEI1 CDK5RAP2 CFAP74 | 4.53e-04 | 720 | 229 | 19 | GO:0000226 |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | MYH3 MYH6 MYH7 MYH10 MYH11 ADGRB1 FKTN HOMER1 DOCK1 KRT8 ATG7 ANKRD23 EP300 | 4.54e-04 | 391 | 229 | 13 | GO:0051146 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 4.73e-04 | 89 | 229 | 6 | GO:1901880 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent cytokinesis | 5.49e-04 | 127 | 229 | 7 | GO:0061640 | |
| GeneOntologyCellularComponent | myosin filament | 1.63e-10 | 25 | 228 | 8 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 4.56e-10 | 28 | 228 | 8 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 7.70e-10 | 59 | 228 | 10 | GO:0016459 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH2 MAP9 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MAP2 MYO9A SPTAN1 SPTBN1 FAM161B KATNAL1 TUBGCP5 CLIP1 KRT71 AMOT SYNE2 ASPM KIF5B DNM1 DNAH9 HOMER1 MTUS2 KRT3 KRT7 KRT8 DYNC2H1 DCTN2 ROR2 CAMSAP3 ANKRD23 LCP1 GSN EFHC2 MYH14 CDK5RAP2 | 1.77e-09 | 1179 | 228 | 38 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH2 MAP9 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MAP2 MYO9A SPTAN1 SPTBN1 FAM161B KATNAL1 TUBGCP5 CLIP1 KRT71 AMOT SYNE2 ASPM KIF5B DNM1 DNAH9 HOMER1 MTUS2 KRT3 KRT7 KRT8 DYNC2H1 DCTN2 ROR2 CAMSAP3 ANKRD23 LCP1 GSN EFHC2 MYH14 CDK5RAP2 | 2.13e-09 | 1187 | 228 | 38 | GO:0099081 |
| GeneOntologyCellularComponent | muscle myosin complex | 1.15e-08 | 16 | 228 | 6 | GO:0005859 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MAP2 MYO7B MYO9A SPTAN1 SPTBN1 NF2 AMOT FLOT2 FLT1 PDCD6IP DCTN2 ANKRD23 LCP1 GSN MYH14 TJP1 | 9.35e-08 | 576 | 228 | 23 | GO:0015629 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MAP9 MAP2 MYO9A FAM161B KATNAL1 TUBGCP5 CLIP1 KRT71 AMOT ASPM KIF5B DNM1 DNAH9 MTUS2 KRT3 KRT7 KRT8 DYNC2H1 DCTN2 ROR2 CAMSAP3 LCP1 GSN EFHC2 CDK5RAP2 | 1.79e-05 | 899 | 228 | 25 | GO:0099513 |
| GeneOntologyCellularComponent | actomyosin | 4.35e-05 | 117 | 228 | 8 | GO:0042641 | |
| GeneOntologyCellularComponent | microtubule | MAP9 MAP2 FAM161B KATNAL1 TUBGCP5 CLIP1 ASPM KIF5B DNM1 DNAH9 MTUS2 DYNC2H1 DCTN2 ROR2 CAMSAP3 EFHC2 CDK5RAP2 | 8.25e-05 | 533 | 228 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH2 MYH3 MYH4 MYH6 MYH7 MYH11 SPTAN1 SPTBN1 SYNE2 HOMER1 KRT8 ANKRD23 | 8.71e-05 | 290 | 228 | 12 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | MYH2 MYH3 MYH4 MYH6 MYH7 SPTAN1 SPTBN1 SYNE2 HOMER1 KRT8 ANKRD23 | 9.64e-05 | 249 | 228 | 11 | GO:0030017 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.73e-04 | 107 | 228 | 7 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.73e-04 | 107 | 228 | 7 | GO:0001725 | |
| GeneOntologyCellularComponent | myofibril | MYH2 MYH3 MYH4 MYH6 MYH7 SPTAN1 SPTBN1 SYNE2 HOMER1 KRT8 ANKRD23 | 2.16e-04 | 273 | 228 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | actin filament bundle | 3.17e-04 | 118 | 228 | 7 | GO:0032432 | |
| GeneOntologyCellularComponent | myosin II filament | 3.53e-04 | 3 | 228 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | cell leading edge | STX2 EPS8 MYH10 MAP2 SPTBN1 CLIP1 TIAM2 SH3YL1 NF2 AMOT SYNE2 FLOT2 LCP1 GSN PHACTR4 | 4.14e-04 | 500 | 228 | 15 | GO:0031252 |
| GeneOntologyCellularComponent | anchoring junction | STX2 MYH2 ARHGAP26 SPTAN1 ADGRB1 TRIM29 FCHSD2 NF2 AMOT SYNE2 FLOT2 KRT8 FLT1 PDCD6IP RTN4 CAMSAP3 ANKRD23 LCP1 GSN SLC3A2 RND3 TJP1 RPL5 | 4.45e-04 | 976 | 228 | 23 | GO:0070161 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 5.45e-04 | 93 | 228 | 6 | GO:0030864 | |
| GeneOntologyCellularComponent | cytoplasmic region | MAP2 KIF5B DNAH9 FLOT2 ATG7 DYNC2H1 CNTRL CAMSAP3 EFHC2 CFAP74 CFAP61 UNC13A | 6.27e-04 | 360 | 228 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | MAP2 KIF5B DNAH9 FLOT2 ATG7 DYNC2H1 CNTRL CAMSAP3 EFHC2 CFAP74 CFAP61 | 7.57e-04 | 317 | 228 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | microtubule end | 7.61e-04 | 38 | 228 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | lamellipodium | 9.87e-04 | 230 | 228 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 1.22e-03 | 43 | 228 | 4 | GO:0097431 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.25e-03 | 238 | 228 | 9 | GO:0097729 | |
| GeneOntologyCellularComponent | growth cone | 1.53e-03 | 245 | 228 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | proton-transporting ATP synthase complex, catalytic core F(1) | 1.73e-03 | 6 | 228 | 2 | GO:0045261 | |
| GeneOntologyCellularComponent | motile cilium | SPEF2 SSX6P SSX8P SSX1 FSIP2 DNAH9 DYNC2H1 CAMSAP3 CFAP74 CFAP61 SLC25A31 | 1.87e-03 | 355 | 228 | 11 | GO:0031514 |
| GeneOntologyCellularComponent | spindle pole | 1.90e-03 | 205 | 228 | 8 | GO:0000922 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.91e-03 | 253 | 228 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | ruffle | 1.96e-03 | 206 | 228 | 8 | GO:0001726 | |
| GeneOntologyCellularComponent | axoneme | 2.02e-03 | 207 | 228 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.08e-03 | 208 | 228 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | I band | 2.35e-03 | 166 | 228 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | microtubule minus-end | 2.40e-03 | 7 | 228 | 2 | GO:0036449 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 2.94e-03 | 129 | 228 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.20e-03 | 223 | 228 | 8 | GO:0098862 | |
| GeneOntologyCellularComponent | actin-based cell projection | 3.58e-03 | 278 | 228 | 9 | GO:0098858 | |
| MousePheno | embryonic lethality, incomplete penetrance | STAG1 SPTAN1 MCM10 KMT2C NF2 FKTN AMOT KRT8 FLT1 ANKFY1 VPS39 APOB THOC2 MFN1 LHX1 PHACTR4 RPL5 EP300 | 9.21e-06 | 410 | 186 | 18 | MP:0011102 |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | STAG1 SPTAN1 MCM10 KMT2C NF2 FKTN AMOT KRT8 FLT1 ANKFY1 VPS39 APOB THOC2 MFN1 LHX1 PHACTR4 RPL5 EP300 | 9.21e-06 | 410 | 186 | 18 | MP:0031660 |
| MousePheno | abnormal lateral ventricle morphology | MYH10 MYO9A SPEF2 SPTAN1 ASPM IMMT PDE11A PDCD6IP EFCAB3 RND3 ARHGAP5 | 1.21e-05 | 164 | 186 | 11 | MP:0000823 |
| MousePheno | increased adrenal gland zona fasciculata size | 2.27e-05 | 5 | 186 | 3 | MP:0014286 | |
| MousePheno | increased ovary tumor incidence | 3.62e-05 | 29 | 186 | 5 | MP:0008000 | |
| MousePheno | enlarged stomach | 6.93e-05 | 33 | 186 | 5 | MP:0003883 | |
| MousePheno | abnormal brain ventricle morphology | MYH10 MYO9A SPEF2 SPTAN1 ASPM LHX5 IMMT PDE11A PDCD6IP EFCAB3 RND3 ARHGAP5 CDK5RAP2 | 1.19e-04 | 286 | 186 | 13 | MP:0000822 |
| MousePheno | increased primordial germ cell apoptosis | 1.24e-04 | 8 | 186 | 3 | MP:0030935 | |
| MousePheno | abnormal primordial germ cell apoptosis | 1.24e-04 | 8 | 186 | 3 | MP:0011610 | |
| MousePheno | abnormal urine progesterone level | 1.76e-04 | 2 | 186 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 1.76e-04 | 2 | 186 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 1.76e-04 | 2 | 186 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 1.76e-04 | 2 | 186 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 1.76e-04 | 2 | 186 | 2 | MP:0011546 | |
| MousePheno | increased gonad tumor incidence | 2.01e-04 | 41 | 186 | 5 | MP:0009590 | |
| Domain | Myosin-like_IQ_dom | 3.64e-13 | 19 | 224 | 9 | IPR027401 | |
| Domain | - | 3.64e-13 | 19 | 224 | 9 | 4.10.270.10 | |
| Domain | Myosin_N | 2.26e-12 | 15 | 224 | 8 | PF02736 | |
| Domain | Myosin_N | 2.26e-12 | 15 | 224 | 8 | IPR004009 | |
| Domain | Myosin_tail_1 | 1.49e-11 | 18 | 224 | 8 | PF01576 | |
| Domain | Myosin_tail | 1.49e-11 | 18 | 224 | 8 | IPR002928 | |
| Domain | Myosin_head_motor_dom | 1.78e-11 | 38 | 224 | 10 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.78e-11 | 38 | 224 | 10 | PS51456 | |
| Domain | Myosin_head | 1.78e-11 | 38 | 224 | 10 | PF00063 | |
| Domain | MYSc | 1.78e-11 | 38 | 224 | 10 | SM00242 | |
| Domain | IQ | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MYO7B MYO9A ASPM LRRIQ3 MYH14 | 2.25e-10 | 81 | 224 | 12 | SM00015 |
| Domain | IQ_motif_EF-hand-BS | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MYO7B MYO9A ASPM LRRIQ3 MYH14 | 7.93e-10 | 90 | 224 | 12 | IPR000048 |
| Domain | IQ | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MYO7B MYO9A ASPM LRRIQ3 MYH14 | 1.17e-09 | 93 | 224 | 12 | PS50096 |
| Domain | IQ | 1.23e-08 | 71 | 224 | 10 | PF00612 | |
| Domain | P-loop_NTPase | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 SAMD9 ABCF3 ATRX MYO7B MYO9A SPEF2 DHX38 MCM3 KATNAL1 ASPM GNL2 KIF5B DNM1 DHX29 DNAH9 DYNC2H1 MFN1 RND3 ARHGAP5 MYH14 TJP1 MCM9 CDC6 REM2 | 3.17e-08 | 848 | 224 | 31 | IPR027417 |
| Domain | CH | 2.70e-05 | 73 | 224 | 7 | PS50021 | |
| Domain | CH-domain | 3.23e-05 | 75 | 224 | 7 | IPR001715 | |
| Domain | Cyt_P450_mitochondrial | 1.43e-04 | 2 | 224 | 2 | IPR002399 | |
| Domain | ACTININ_2 | 1.49e-04 | 23 | 224 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.49e-04 | 23 | 224 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.49e-04 | 23 | 224 | 4 | IPR001589 | |
| Domain | Keratin_2_head | 1.77e-04 | 24 | 224 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 1.77e-04 | 24 | 224 | 4 | PF16208 | |
| Domain | CH | 1.92e-04 | 70 | 224 | 6 | PF00307 | |
| Domain | Keratin_II | 2.45e-04 | 26 | 224 | 4 | IPR003054 | |
| Domain | KRAB_RELATED | 2.62e-04 | 11 | 224 | 3 | PS50806 | |
| Domain | Cyt_P450_CS | 4.26e-04 | 53 | 224 | 5 | IPR017972 | |
| Domain | Krueppel-associated_box-rel | 4.45e-04 | 13 | 224 | 3 | IPR003655 | |
| Domain | CYTOCHROME_P450 | 5.98e-04 | 57 | 224 | 5 | PS00086 | |
| Domain | - | 6.48e-04 | 58 | 224 | 5 | 1.10.630.10 | |
| Domain | p450 | 6.48e-04 | 58 | 224 | 5 | PF00067 | |
| Domain | - | SAMD9 ABCF3 ATRX MYO7B SPEF2 DHX38 MCM3 KATNAL1 GNL2 DNM1 DHX29 DNAH9 DYNC2H1 MFN1 RND3 ARHGAP5 TJP1 MCM9 CDC6 REM2 | 6.86e-04 | 746 | 224 | 20 | 3.40.50.300 |
| Domain | Cyt_P450 | 7.58e-04 | 60 | 224 | 5 | IPR001128 | |
| Domain | RhoGAP_dom | 1.02e-03 | 64 | 224 | 5 | IPR000198 | |
| Domain | RHOGAP | 1.02e-03 | 64 | 224 | 5 | PS50238 | |
| Domain | - | 1.02e-03 | 64 | 224 | 5 | 1.10.555.10 | |
| Domain | CH | 1.09e-03 | 65 | 224 | 5 | SM00033 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.46e-06 | 70 | 176 | 8 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 5.98e-06 | 132 | 176 | 10 | M11355 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYH10 MYH11 MYO9A ARHGAP26 SPTAN1 SPTBN1 MTMR1 CLIP1 TIAM2 STX5 NF2 KIF5B ARAP2 DOCK1 FLOT2 ANKFY1 MFN1 FMNL3 RND3 ARHGAP5 MYH14 | 6.01e-05 | 649 | 176 | 21 | MM15690 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.19e-04 | 21 | 176 | 4 | M27494 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.20e-04 | 62 | 176 | 6 | M39653 | |
| Pubmed | ATP5F1E MYH2 MAP9 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 STAG1 ATRX RSL1D1 SPEF2 SPTAN1 SPTBN1 LYST BBX KRT71 FAM186A SYNE2 ASPM KIF5B HSD17B4 IMMT CAVIN2 GOLGB1 KRT3 KRT7 KRT8 CNTRL CAMSAP3 APOB TMEM43 LCP1 SLC3A2 TRAP1 GTF3C1 MYH14 TJP1 SUPT16H CFAP74 ATM CUX1 SLC25A31 | 4.74e-17 | 1442 | 236 | 44 | 35575683 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH10 ATRX RSL1D1 SPTAN1 SPTBN1 DHX38 MCM3 UPF3B SLC38A1 AMOT GNL2 KIF5B MMP9 HSD17B4 DHX29 IMMT FLOT2 ANKFY1 PDCD6IP DYNC2H1 RTN4 OTUB1 APOB TMEM43 THOC2 SLC3A2 IARS2 TRAP1 GTF3C1 MYH14 SUPT16H EIF3B ATM RPL5 FTSJ3 | 4.86e-11 | 1425 | 236 | 35 | 30948266 |
| Pubmed | EPS8 MAP9 MYH6 MYH10 MYH11 MAP2 MYO9A ARHGAP26 SPTAN1 SPTBN1 MTMR1 UPF3B AMOT KIF5B DNM1 DHX29 IMMT HOMER1 MTUS2 FLOT2 PDCD6IP DCTN2 RTN4 CAMSAP3 GSN SLC3A2 PRKRA ARHGAP5 MYH14 TJP1 CLMN USP54 HADH RPL5 UNC13A | 5.45e-11 | 1431 | 236 | 35 | 37142655 | |
| Pubmed | 2.86e-10 | 7 | 236 | 5 | 16819597 | ||
| Pubmed | MAP9 ABCF3 ATRX RSL1D1 ARHGAP26 SPTBN1 DHX38 TIAM2 KMT2C STX5 NF2 AMOT VPS35L UBE2Q2 GOLGB1 PDCD6IP SPOPL VPS39 CNTRL AKNAD1 APOB DEPDC1 FAM171B THOC2 ARHGAP5 CLMN CDK5RAP2 ULK2 IPMK | 3.74e-10 | 1084 | 236 | 29 | 11544199 | |
| Pubmed | MYH4 MYH10 MYH11 SPTAN1 KIF5B HSD17B4 KRT7 KRT8 TMEM43 GSN MYH14 TJP1 EIF3B | 7.62e-10 | 191 | 236 | 13 | 33762435 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | EPS8 STAG1 ATRX RSL1D1 SPTAN1 SPTBN1 MTMR1 TUBGCP5 NF2 HSD17B4 DHX29 IMMT MTUS2 CAVIN2 CAMSAP3 PRKRA ARHGAP5 CLMN RPL5 | 8.16e-10 | 475 | 236 | 19 | 31040226 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 MAP2 MYO9A SPTAN1 SPTBN1 LYST NSD3 FSIP2 STOX2 STX5 AMOT SYNE2 CCDC138 KIF5B GOLGB1 ARAP2 FLOT2 KRT8 PDCD6IP ROR2 CAMSAP3 TJP1 CLMN PHACTR4 USP54 | 1.29e-09 | 861 | 236 | 25 | 36931259 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | MCM3 KIF5B ALDH1A3 HSD17B4 PDCD6IP OTUB1 GSN SLC3A2 IARS2 TRAP1 TJP1 EIF3B | 4.97e-09 | 182 | 236 | 12 | 30711629 |
| Pubmed | MYH10 MYH11 MYO9A SPTAN1 SPTBN1 NSD3 KMT2C KIF5B GOLGB1 DOCK1 KRT8 PDCD6IP DCTN2 CNTRL DUSP16 IRAG2 EP300 CUX1 | 7.64e-09 | 486 | 236 | 18 | 20936779 | |
| Pubmed | MYH2 MYH4 VPS33A STX5 AMOT KIF5B HSD17B4 IMMT DOCK1 ANKFY1 PDCD6IP ATG7 GTF3C1 TJP1 SUPT16H HADH ULK2 | 9.83e-09 | 437 | 236 | 17 | 20562859 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CPNE2 MYH10 SAMD9 RSL1D1 SPTAN1 SPTBN1 DHX38 MCM3 TRIM29 NSD3 GNL2 KIF5B IMMT KRT3 FLOT2 KRT8 PDCD6IP TMEM43 THOC2 GSN SLC3A2 PRKRA IARS2 GTF3C1 TJP1 SUPT16H EIF3B RPL5 FTSJ3 | 1.04e-08 | 1257 | 236 | 29 | 36526897 |
| Pubmed | 1.05e-08 | 12 | 236 | 5 | 8424456 | ||
| Pubmed | 1.39e-08 | 92 | 236 | 9 | 37343697 | ||
| Pubmed | ATP5F1E MYH2 MYH10 RSL1D1 SPTAN1 SPTBN1 MCM3 COG3 STX5 PELO SYNE2 VPS35L GNL2 DHX29 FLOT2 PDCD6IP DCTN2 RTN4 OTUB1 TMEM43 THOC2 GSN SLC3A2 PRKRA IARS2 TRAP1 GTF3C1 SUPT16H EIF3B ATM CUX1 | 1.52e-08 | 1440 | 236 | 31 | 30833792 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH2 MYH4 MYH7 CYP4F8 MYH10 ATRX RSL1D1 DHX38 MCM3 MYCBPAP KMT2C PELO ASPM GNL2 SPOP KIF5B MNAT1 KRT8 HTR1E PDCD6IP SFSWAP RTN4 GSN SLC3A2 PRKRA IBTK CCDC59 KCNIP4 FTSJ3 | 1.65e-08 | 1284 | 236 | 29 | 17353931 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP5F1E MYH10 MYH11 RSL1D1 SPTAN1 SPTBN1 VPS33A MCM3 UPF3B CCDC144CP CLIP1 KIF5B DHX29 IMMT GOLGB1 FLOT2 CDV3 DCTN2 LCP1 THOC2 MYH14 EIF3B RPL5 | 2.11e-08 | 847 | 236 | 23 | 35235311 |
| Pubmed | TET2 RSL1D1 SPTAN1 SPTBN1 RETSAT KMT2C STX5 KIF5B HSD17B4 IMMT GOLGB1 KRT8 CDV3 TMEM43 SLC3A2 PRKRA TRAP1 MYH14 SUPT16H EIF3B RPL5 | 2.17e-08 | 711 | 236 | 21 | 33022573 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH7 MYH10 RSL1D1 SPTAN1 SPTBN1 MTMR1 MCM3 PELO KRT71 AMOT KIF5B HOMER1 KRT8 CDV3 PDCD6IP DCTN2 OTUB1 CAMSAP3 LCP1 GSN PRKRA TRAP1 GTF3C1 SUPT16H EIF3B RPL5 FTSJ3 | 2.40e-08 | 1149 | 236 | 27 | 35446349 |
| Pubmed | MYH11 RSL1D1 MCM3 STX5 AMOT KIF5B HSD17B4 IMMT GOLGB1 FLOT2 PDCD6IP SFSWAP DCTN2 OTUB1 CCDC80 GSN SLC3A2 TRAP1 MYH14 TJP1 SUPT16H EIF3B | 2.56e-08 | 786 | 236 | 22 | 29128334 | |
| Pubmed | 2.63e-08 | 14 | 236 | 5 | 21071677 | ||
| Pubmed | MYH10 RSL1D1 SPTAN1 SPTBN1 DHX38 SYNE2 GNL2 KIF5B IMMT PDCD6IP LCP1 THOC2 PRKRA IARS2 GTF3C1 MYH14 TJP1 ATM RPL5 FTSJ3 | 2.64e-08 | 653 | 236 | 20 | 22586326 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYH10 MAP2 SPTAN1 SPTBN1 MTMR1 MCM3 NSD3 BBX GNL2 PCDH15 DNM1 HSD17B4 FLOT2 KRT8 PDCD6IP SFSWAP TMEM43 THOC2 PRKRA GTF3C1 TJP1 SUPT16H EIF3B ATM RPL5 UNC13A | 2.85e-08 | 1082 | 236 | 26 | 38697112 |
| Pubmed | 3.07e-08 | 6 | 236 | 4 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 3.07e-08 | 6 | 236 | 4 | 10588881 | |
| Pubmed | ATRX MAP2 RSL1D1 SPTAN1 SPTBN1 MTMR1 STX5 NF2 SYNE2 CCDC138 ASPM GNL2 DHX29 IMMT GOLGB1 FLOT2 DYNC2H1 DCTN2 RTN4 ROR2 OTUB1 SLC3A2 IARS2 CLMN PHACTR4 SUPT16H CDK5RAP2 ATM RPL5 CUX1 FTSJ3 | 3.16e-08 | 1487 | 236 | 31 | 33957083 | |
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | EPS8 RSL1D1 SPTAN1 SPTBN1 COG3 TIAM2 TMEM132C STX5 NF2 ATG7 THOC2 POLR3F EFHC2 | 5.28e-08 | 272 | 236 | 13 | 18187620 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | CPNE2 STX2 EPS8 MYH6 MYH10 MYH11 MAP2 SPTAN1 SPTBN1 MTMR1 KIF5B DNM1 IMMT HOMER1 OTUB1 OGN GSN SLC3A2 TRAP1 | 6.05e-08 | 621 | 236 | 19 | 22794259 |
| Pubmed | MYH10 SPTAN1 SPTBN1 DHX38 MTMR1 NSD3 SLC38A1 NUDT12 NF2 SYNE2 CCDC138 GNL2 HSD17B4 TRIM36 KRT8 CAMSAP3 FAM171B SLC3A2 POSTN ARHGAP5 TJP1 DUSP16 SUPT16H CDK5RAP2 FTSJ3 | 6.28e-08 | 1049 | 236 | 25 | 27880917 | |
| Pubmed | 7.12e-08 | 7 | 236 | 4 | 35210422 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 7.12e-08 | 7 | 236 | 4 | 29758057 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ABCF3 RSL1D1 SPTAN1 SPTBN1 TRIM29 SLC38A1 STX5 NF2 KIF5B DHX29 GOLGB1 RTN4 FAM171B SLC3A2 ARHGAP5 TJP1 CLMN PHACTR4 | 7.49e-08 | 565 | 236 | 18 | 25468996 |
| Pubmed | MYH10 RSL1D1 DHX38 NSD3 GNL2 PCYT2 HSD17B4 CAVIN2 SFSWAP DCTN2 CPS1 THOC2 GSN SLC3A2 ARHGAP5 GTF3C1 MYH14 TJP1 EIF3B RPL5 CUX1 FTSJ3 | 9.41e-08 | 847 | 236 | 22 | 35850772 | |
| Pubmed | RSL1D1 MCM3 MCM10 SLC38A1 STX5 BBX NF2 AMOT GOLGB1 ARAP2 PDCD6IP SFSWAP CNTRL APOB FAM171B SLC3A2 IARS2 TJP1 PHACTR4 CDK5RAP2 CUX1 | 9.68e-08 | 777 | 236 | 21 | 35844135 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 SPTAN1 SPTBN1 TRIM29 HSD17B4 IMMT KRT7 DCTN2 CCDC80 GSN MYH14 RPL5 SLC25A31 | 1.14e-07 | 647 | 236 | 19 | 26618866 |
| Pubmed | EPS8 SPTAN1 SPTBN1 ADGRB1 MTMR1 STOX2 LSM11 HOMER1 NTRK2 FAM171B TJP1 | 1.20e-07 | 197 | 236 | 11 | 36604605 | |
| Pubmed | 1.42e-07 | 8 | 236 | 4 | 3864153 | ||
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 1.42e-07 | 8 | 236 | 4 | 12634303 | |
| Pubmed | MYH2 MYH4 MYH7 MYH10 SPTAN1 SPTBN1 IMMT KRT7 KRT8 GSN MYH14 RPL5 CPNE7 | 1.98e-07 | 305 | 236 | 13 | 33194618 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MAP9 POP4 RSL1D1 VPS35L GNL2 HSD17B4 GOLGB1 VPS39 RTN4 CNTRL TMEM43 GSN PRKRA IBTK MYH14 CDK5RAP2 EIF3B USP54 CUX1 FTSJ3 | 2.66e-07 | 754 | 236 | 20 | 33060197 |
| Pubmed | MYH10 MAP2 SPTAN1 SPTBN1 VPS33A ADGRB1 TRIM29 STX5 KIF5B DHX29 HOMER1 FLOT2 PDCD6IP NTRK2 RTN4 CAMSAP3 TMEM43 FAM171B SLC3A2 PRKRA TRAP1 TJP1 EIF3B RPL5 UNC13A | 2.94e-07 | 1139 | 236 | 25 | 36417873 | |
| Pubmed | 3.09e-07 | 3 | 236 | 3 | 8620598 | ||
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 3.09e-07 | 3 | 236 | 3 | 1939265 | |
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 3.09e-07 | 3 | 236 | 3 | 1694848 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | MYH2 MYH7 MYH10 RSL1D1 SPTAN1 SPTBN1 MCM3 TRIM29 KRT8 PDCD6IP GSN PRKRA MYH14 TJP1 SUPT16H EIF3B RPL5 CUX1 | 3.38e-07 | 626 | 236 | 18 | 33644029 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | MYH10 RSL1D1 SPTAN1 IMMT FLOT2 TMEM43 GSN SLC3A2 IBTK TJP1 SUPT16H FTSJ3 | 3.49e-07 | 268 | 236 | 12 | 33024031 |
| Pubmed | MYH10 RSL1D1 SPTAN1 SPTBN1 COG3 TRIM29 CLIP1 GNL2 IMMT CAVIN2 VPS39 SLC3A2 PRKRA MYH14 TJP1 USP54 | 4.13e-07 | 503 | 236 | 16 | 36217030 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | EPS8 MYH10 MCM3 CLIP1 CCDC138 KIF5B HSD17B4 FLOT2 KRT8 CDV3 DCTN2 CNTRL CAMSAP3 LCP1 ARHGAP5 IBTK IARS2 TJP1 PHACTR4 USP54 FTSJ3 | 4.47e-07 | 853 | 236 | 21 | 28718761 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | MYH10 KIF5B IMMT GOLGB1 PDCD6IP CPS1 SLC3A2 IARS2 TRAP1 EIF3B | 4.53e-07 | 179 | 236 | 10 | 36261009 |
| Pubmed | RSL1D1 SPTAN1 UPF3B MCM10 NSD3 BBX AMOT CCDC138 KIF5B MNAT1 HOMER1 DCTN2 LCP1 THOC2 CCDC59 MYH14 SUPT16H EP300 | 5.21e-07 | 645 | 236 | 18 | 25281560 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | MYH10 MYH11 RSL1D1 SPTAN1 SPTBN1 MCM3 IMMT GOLGB1 FLOT2 KRT7 KRT8 CPS1 GSN SLC3A2 MYH14 TJP1 RPL5 | 5.56e-07 | 580 | 236 | 17 | 35676659 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH10 MYH11 RSL1D1 SPTAN1 SPTBN1 MCM3 UPF3B NF2 GNL2 KIF5B FLOT2 APOB CPS1 THOC2 GSN SLC3A2 CCDC59 MYH14 SUPT16H EIF3B RPL5 FTSJ3 | 6.43e-07 | 949 | 236 | 22 | 36574265 |
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 6.57e-07 | 11 | 236 | 4 | 16024798 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | MYH10 MYH11 SPTAN1 SPTBN1 FCHSD2 DOCK1 OTUB1 TRAP1 MYH14 IRAG2 CPNE7 | 7.00e-07 | 235 | 236 | 11 | 30258100 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH10 MYH11 SPTAN1 SPTBN1 VPS33A MCM3 COG3 IMMT KRT8 PDCD6IP DYNC2H1 RTN4 CNTRL GSN SLC3A2 IARS2 TRAP1 MYH14 EIF3B RPL5 | 7.67e-07 | 807 | 236 | 20 | 30575818 |
| Pubmed | TET2 STAG1 ATRX RSL1D1 SPTAN1 SPTBN1 NAP1L2 TUBGCP5 ADARB1 SH3YL1 NF2 VPS35L DNM1 HSD17B4 MNAT1 IMMT MTUS2 VPS39 PRKRA ARHGAP5 MYH14 TJP1 ATM USP54 EP300 CUX1 | 7.81e-07 | 1285 | 236 | 26 | 35914814 | |
| Pubmed | TET2 ARHGAP26 ZC4H2 TIAM2 TPCN1 KMT2C STOX2 USP38 AMOT PDCD6IP VPS39 RTN4 FMNL3 IBTK RALGPS1 CDK5RAP2 | 8.02e-07 | 529 | 236 | 16 | 14621295 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | RSL1D1 SPTAN1 SPTBN1 MCM3 KIF5B HSD17B4 IMMT ANKFY1 PDCD6IP RTN4 LCP1 GSN SLC3A2 IARS2 MYH14 SUPT16H EIF3B | 1.04e-06 | 607 | 236 | 17 | 39147351 |
| Pubmed | MYH7 SPTAN1 SPTBN1 TRIM29 CLIP1 TIAM2 STX5 SYNE2 CCDC138 IMMT GOLGB1 PDCD6IP DYNC2H1 VPS39 CNTRL APOB LHX1 IRAG2 EP300 | 1.15e-06 | 754 | 236 | 19 | 35906200 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYH10 ATRX MAP2 MYO9A MYT1 KATNAL1 ACVR2B COG3 ZC4H2 ADARB1 SH3YL1 KMT2C NF2 VPS35L GOLGB1 DOCK1 PDCD6IP ATG7 ROR2 CAMSAP3 GTF3C1 MYH14 TJP1 CLMN RALGPS1 EP300 CUX1 CPNE7 | 1.21e-06 | 1489 | 236 | 28 | 28611215 |
| Pubmed | 1.23e-06 | 4 | 236 | 3 | 19342457 | ||
| Pubmed | 1.23e-06 | 4 | 236 | 3 | 8482409 | ||
| Pubmed | STEF/TIAM2-mediated Rac1 activity at the nuclear envelope regulates the perinuclear actin cap. | 1.23e-06 | 4 | 236 | 3 | 29844364 | |
| Pubmed | PLPP5 SWT1 ARHGAP26 TNIP3 ZSWIM2 SLC38A1 NUDT12 FCHSD2 AMOT TRIM36 DHX29 CNTRL OGN MFN1 SLC3A2 IBTK RALGPS1 PHACTR4 | 1.25e-06 | 686 | 236 | 18 | 29987050 | |
| Pubmed | MYH10 POP4 SPTAN1 SPTBN1 KIF5B CAVIN2 GOLGB1 FLOT2 KRT7 KRT8 CDV3 GSN TJP1 | 1.28e-06 | 360 | 236 | 13 | 33111431 | |
| Pubmed | SPTAN1 MCM3 NSD3 KMT2C NF2 AMOT KIF5B CDV3 DCTN2 THOC2 SLC3A2 GTF3C1 TJP1 PHACTR4 EP300 CUX1 | 1.30e-06 | 549 | 236 | 16 | 38280479 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.41e-06 | 13 | 236 | 4 | 8404542 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH10 ABCF3 RSL1D1 SPTAN1 SPTBN1 DHX38 MCM3 UPF3B PELO SYNE2 GNL2 KIF5B HSD17B4 IMMT GOLGB1 KRT7 KRT8 CDV3 PDCD6IP CPS1 GSN SLC3A2 TJP1 SUPT16H EIF3B RPL5 FTSJ3 | 1.44e-06 | 1415 | 236 | 27 | 28515276 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYH10 ATRX RSL1D1 DHX38 UPF3B GNL2 KIF5B DHX29 GOLGB1 FLOT2 CDV3 RTN4 THOC2 SLC3A2 IBTK IARS2 TRAP1 TJP1 CLMN RPL5 FTSJ3 | 1.89e-06 | 934 | 236 | 21 | 33916271 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYH7 MYH10 ABCF3 STAG1 MTMR1 CHI3L2 TRIM29 IRF9 BBX KIF5B ANKRD20A1 DEPDC1 CPS1 FAAP100 P3H4 IARS2 CCDC59 GTF3C1 EP300 CUX1 | 1.92e-06 | 857 | 236 | 20 | 25609649 |
| Pubmed | 1.96e-06 | 14 | 236 | 4 | 24938781 | ||
| Pubmed | 1.96e-06 | 14 | 236 | 4 | 27184118 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATRX RSL1D1 DHX38 MCM3 AMOT GNL2 DHX29 VPS39 GTF3C1 MYH14 SUPT16H USP54 RPL5 FTSJ3 | 2.21e-06 | 440 | 236 | 14 | 34244565 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RSL1D1 MCM3 AMOT SYNE2 GNL2 KIF5B HSD17B4 IMMT GOLGB1 FLOT2 PDCD6IP THOC2 GSN SLC3A2 TRAP1 GTF3C1 MYH14 TJP1 SUPT16H EIF3B RPL5 FTSJ3 | 2.23e-06 | 1024 | 236 | 22 | 24711643 |
| Pubmed | MYH10 SPTAN1 SPTBN1 CLIP1 KIF5B IMMT ANKFY1 DCTN2 TMEM43 REST SLC3A2 EIF3B | 2.24e-06 | 320 | 236 | 12 | 28685749 | |
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 2.66e-06 | 15 | 236 | 4 | 24852826 | |
| Pubmed | MYH10 MYH11 SPTBN1 MCM3 TRIM29 ALDH1A3 HSD17B4 LCP1 GSN SLC3A2 MYH14 SUPT16H | 2.80e-06 | 327 | 236 | 12 | 31409639 | |
| Pubmed | MYH10 SPTAN1 SPTBN1 MCM3 CLIP1 STOX2 SYNE2 KIF5B DNM1 HOMER1 GOLGB1 ANKFY1 PDCD6IP NTRK2 CAMSAP3 GSN TJP1 SUPT16H CDK5RAP2 UNC13A CUX1 | 3.04e-06 | 963 | 236 | 21 | 28671696 | |
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 3.05e-06 | 5 | 236 | 3 | 2277065 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 3.05e-06 | 5 | 236 | 3 | 12919077 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 24236012 | ||
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 33871354 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 3.05e-06 | 5 | 236 | 3 | 3829126 | |
| Pubmed | Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. | 3.05e-06 | 5 | 236 | 3 | 24091702 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 6196357 | ||
| Pubmed | 3.38e-06 | 60 | 236 | 6 | 20682791 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 3.53e-06 | 16 | 236 | 4 | 19922871 | |
| Pubmed | MYH11 POP4 RSL1D1 KRT71 AMOT KIF5B DHX29 IMMT KRT3 KRT7 KRT8 DCTN2 REST LCP1 SLC3A2 TRAP1 MYH14 SUPT16H EIF3B RPL5 SLC25A31 CPNE7 FTSJ3 | 4.44e-06 | 1153 | 236 | 23 | 29845934 | |
| Pubmed | 4.59e-06 | 17 | 236 | 4 | 16124007 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATP5F1E MYH2 MYH3 MYH6 MYH7 SCRT1 ATRX UPF3B RETSAT LYST CCDC138 MNAT1 ATP5F1EP2 ANKFY1 GTF3C1 SUPT16H CDK5RAP2 EIF3B EP300 IPMK | 4.70e-06 | 910 | 236 | 20 | 36736316 |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | CPNE2 MYH10 MYH11 SPTAN1 SPTBN1 AMOT FLOT2 GSN TRAP1 MYH14 SLC25A31 | 5.01e-06 | 288 | 236 | 11 | 31501420 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH10 SPTAN1 SPTBN1 MCM3 PDCD6IP GSN SLC3A2 IARS2 TRAP1 ZNF804B SUPT16H EIF3B RPL5 CUX1 | 5.58e-06 | 477 | 236 | 14 | 31300519 |
| Pubmed | Coordinated metabolic responses to cyclophilin D deletion in the developing heart. | 5.87e-06 | 18 | 236 | 4 | 38414851 | |
| Pubmed | 5.87e-06 | 18 | 236 | 4 | 28049845 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 28381556 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 6.08e-06 | 6 | 236 | 3 | 10077619 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 9068972 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 30044719 | ||
| Pubmed | MYH10 SPTAN1 SPTBN1 KIF5B IMMT KRT7 KRT8 GSN MYH14 TJP1 FTSJ3 | 6.29e-06 | 295 | 236 | 11 | 26209609 | |
| Pubmed | POP4 RSL1D1 UPF3B GNL2 MMP9 IMMT ANKFY1 LCP1 GSN CCDC59 GTF3C1 SUPT16H RPL5 FTSJ3 | 6.43e-06 | 483 | 236 | 14 | 36912080 | |
| Interaction | FGD5 interactions | MYH4 MYH10 MYH11 SPTAN1 MCM3 KIF5B HSD17B4 KRT7 KRT8 TMEM43 GSN MYH14 TJP1 EIF3B | 1.25e-07 | 207 | 231 | 14 | int:FGD5 |
| Interaction | LATS1 interactions | TET2 MYH2 MYH3 MYH4 MYH6 MYH7 RSL1D1 SPTAN1 SPTBN1 NF2 AMOT CCDC138 SPOP ANKFY1 REST MYH14 TJP1 CDK5RAP2 USP54 FTSJ3 | 1.89e-07 | 440 | 231 | 20 | int:LATS1 |
| Interaction | YWHAH interactions | TET2 MYH11 MAP2 MYO9A SPTAN1 SPTBN1 DHX38 LYST NSD3 STOX2 STX5 AMOT SYNE2 CCDC138 PCYT2 SPOP KIF5B HOMER1 ARAP2 FLOT2 KRT8 PDCD6IP SFSWAP CNTRL ROR2 CAMSAP3 IARS2 TJP1 CLMN DUSP16 PHACTR4 USP54 | 1.24e-06 | 1102 | 231 | 32 | int:YWHAH |
| Interaction | YAP1 interactions | CPNE2 MYH10 MYH11 MAP2 SPTAN1 SPTBN1 MCM3 NSD3 KMT2C NF2 AMOT KIF5B IMMT HOMER1 FLOT2 CDV3 DCTN2 RTN4 OTUB1 THOC2 GSN SLC3A2 TRAP1 GTF3C1 MYH14 TJP1 SUPT16H EIF3B EP300 CUX1 SLC25A31 | 3.12e-06 | 1095 | 231 | 31 | int:YAP1 |
| Interaction | KCNA3 interactions | MYO9A SPEF2 SPTBN1 MTMR1 MCM3 CLIP1 SLC38A1 KMT2C NF2 KIF5B DNM1 DHX29 IMMT GOLGB1 DOCK1 FLOT2 PDCD6IP NTRK2 RTN4 ROR2 AKNAD1 THOC2 SLC3A2 PHACTR4 CDK5RAP2 RPL5 | 8.31e-06 | 871 | 231 | 26 | int:KCNA3 |
| Interaction | KCTD13 interactions | EPS8 MAP9 MYH6 MYH10 MYH11 MAP2 MYO9A ARHGAP26 SPTAN1 SPTBN1 MTMR1 UPF3B AMOT KIF5B DNM1 DHX29 IMMT HOMER1 MTUS2 FLOT2 PDCD6IP DCTN2 RTN4 CAMSAP3 GSN SLC3A2 PRKRA ARHGAP5 MYH14 TJP1 CLMN USP54 HADH RPL5 UNC13A | 9.73e-06 | 1394 | 231 | 35 | int:KCTD13 |
| Interaction | PRKAG2 interactions | 1.27e-05 | 68 | 231 | 7 | int:PRKAG2 | |
| Interaction | DCTN1 interactions | MAP9 ABCF3 MAP2 SPTBN1 MCM3 UPF3B TRIM29 CLIP1 CCDC138 TRIM36 DHX29 KRT3 KRT8 ANKFY1 DCTN2 CAMSAP3 IBTK SUPT16H | 1.84e-05 | 497 | 231 | 18 | int:DCTN1 |
| Interaction | CDK7 interactions | STX2 MYH10 SPTBN1 DHX38 MCM3 GNL2 HSD17B4 MNAT1 IMMT CNTRL SLC3A2 TRAP1 GTF3C1 SUPT16H RPL5 EP300 CUX1 FTSJ3 | 2.05e-05 | 501 | 231 | 18 | int:CDK7 |
| Interaction | PIBF1 interactions | CPNE2 TNIP3 VPS33A AMOT CCDC138 MTUS2 KRT8 CNTRL ANKRD23 EFHC2 CDK5RAP2 | 2.06e-05 | 200 | 231 | 11 | int:PIBF1 |
| Interaction | PCNT interactions | SPTAN1 SPTBN1 NAP1L2 AMOT CCDC138 DNM1 KRT8 ANKFY1 DCTN2 CNTRL DUSP16 CDK5RAP2 | 2.34e-05 | 241 | 231 | 12 | int:PCNT |
| Interaction | CXADR interactions | MTMR1 STX5 NF2 AMOT SYNE2 GOLGB1 FLOT2 NTRK2 ROR2 FAM171B SLC3A2 RND3 TJP1 PHACTR4 USP54 | 2.51e-05 | 369 | 231 | 15 | int:CXADR |
| Interaction | ANKRD20A4P interactions | 2.90e-05 | 6 | 231 | 3 | int:ANKRD20A4P | |
| Interaction | ASAH2 interactions | 2.90e-05 | 6 | 231 | 3 | int:ASAH2 | |
| Interaction | KIF20A interactions | MYH10 MYH11 RSL1D1 SPTAN1 SPTBN1 FAM161B MCM3 TRIM29 NSD3 NF2 SYNE2 HSD17B4 IMMT FLOT2 SFSWAP DYNC2H1 APOB CPS1 THOC2 MYH14 TJP1 SUPT16H IRAG2 CDK5RAP2 CYP4F3 USP54 RPL5 FTSJ3 | 2.99e-05 | 1052 | 231 | 28 | int:KIF20A |
| Interaction | TRIM36 interactions | 4.35e-05 | 144 | 231 | 9 | int:TRIM36 | |
| Interaction | S100A4 interactions | 4.35e-05 | 144 | 231 | 9 | int:S100A4 | |
| Interaction | SEPTIN10 interactions | ADARB1 CCDC138 IMMT GOLGB1 KRT8 NTRK2 SLC3A2 DUSP16 CDK5RAP2 | 4.35e-05 | 144 | 231 | 9 | int:SEPTIN10 |
| Interaction | HDAC4 interactions | EPS8 STAG1 ATRX RSL1D1 SPTAN1 SPTBN1 MTMR1 FCHSD2 NF2 KIF5B DHX29 MTUS2 CAVIN2 CAMSAP3 REST PRKRA EFHC2 ARHGAP5 CLMN EIF3B ATM RPL5 | 4.92e-05 | 744 | 231 | 22 | int:HDAC4 |
| Interaction | ANKRD20A2P interactions | 5.03e-05 | 7 | 231 | 3 | int:ANKRD20A2P | |
| Interaction | HAUS1 interactions | 5.17e-05 | 183 | 231 | 10 | int:HAUS1 | |
| Interaction | CIT interactions | MYH10 MYH11 STAG1 RSL1D1 CYP11B1 SPTAN1 SPTBN1 DHX38 MCM3 UPF3B PELO NF2 SYNE2 GNL2 IMMT HOMER1 FLOT2 DYNC2H1 APOB CPS1 THOC2 GSN SLC3A2 RND3 TRAP1 MYH14 TJP1 SUPT16H CDK5RAP2 EIF3B RPL5 CUX1 SLC25A31 FTSJ3 | 5.32e-05 | 1450 | 231 | 34 | int:CIT |
| Interaction | CEP350 interactions | 5.68e-05 | 149 | 231 | 9 | int:CEP350 | |
| Interaction | SPOPL interactions | 6.12e-05 | 37 | 231 | 5 | int:SPOPL | |
| Interaction | PRICKLE1 interactions | 6.35e-05 | 60 | 231 | 6 | int:PRICKLE1 | |
| Interaction | MECOM interactions | MYH2 MYH4 MYH7 ZC4H2 GNL2 IMMT VPS39 THOC2 SLC3A2 L3MBTL1 TJP1 SUPT16H RPL5 FTSJ3 | 7.10e-05 | 358 | 231 | 14 | int:MECOM |
| Interaction | GRIN1 interactions | 7.34e-05 | 154 | 231 | 9 | int:GRIN1 | |
| Interaction | MAPRE3 interactions | MAP9 MAP2 FAM161B MCM10 CLIP1 TRIM36 DCTN2 CAMSAP3 IBTK IARS2 CDK5RAP2 | 7.36e-05 | 230 | 231 | 11 | int:MAPRE3 |
| Interaction | IFI16 interactions | POP4 SAMD9 RSL1D1 SPTAN1 DHX38 UPF3B PELO ASPM GNL2 KIF5B DHX29 ANKFY1 PDCD6IP DCTN2 TMEM43 PRKRA MYH14 TJP1 SUPT16H EP300 FTSJ3 | 7.92e-05 | 714 | 231 | 21 | int:IFI16 |
| Interaction | ECT2 interactions | MYH10 MYH11 RSL1D1 SPTAN1 SPTBN1 FAM161B LYST PELO ASPM HSD17B4 DNAH9 IMMT FLOT2 PDCD6IP OTUB1 CPS1 GSN SLC3A2 TRAP1 MYH14 TJP1 SUPT16H RPL5 CUX1 | 8.91e-05 | 887 | 231 | 24 | int:ECT2 |
| Interaction | DBR1 interactions | 8.99e-05 | 40 | 231 | 5 | int:DBR1 | |
| Interaction | UBA3 interactions | 9.10e-05 | 92 | 231 | 7 | int:UBA3 | |
| Interaction | CHMP4B interactions | MYH10 MYH11 ATRX RSL1D1 SPTAN1 SPTBN1 FAM161B MCM3 NF2 IMMT GOLGB1 FLOT2 PDCD6IP CPS1 GSN TRAP1 MYH14 TJP1 SUPT16H CDK5RAP2 RPL5 | 1.02e-04 | 727 | 231 | 21 | int:CHMP4B |
| Interaction | RHOB interactions | EPS8 MYO9A RSL1D1 SPTAN1 SPTBN1 MTMR1 UPF3B MCM10 TIAM2 SLC38A1 NF2 IMMT DOCK1 FLOT2 ROR2 DEPDC1 FAM171B SLC3A2 ARHGAP5 CCDC59 TJP1 PHACTR4 SUPT16H | 1.05e-04 | 840 | 231 | 23 | int:RHOB |
| Interaction | SIRT6 interactions | MYH7 ABCF3 ATRX RSL1D1 DHX38 MCM3 AMOT GNL2 DHX29 MNAT1 KRT3 VPS39 GTF3C1 MYH14 SUPT16H USP54 RPL5 EP300 FTSJ3 | 1.21e-04 | 628 | 231 | 19 | int:SIRT6 |
| Interaction | AFDN interactions | CPNE2 SLC38A1 GNL2 MTUS2 GOLGB1 FLOT2 NTRK2 ROR2 FAM171B SLC3A2 TJP1 PHACTR4 USP54 | 1.31e-04 | 333 | 231 | 13 | int:AFDN |
| Interaction | DISC1 interactions | MYH7 SPTAN1 SPTBN1 DHX38 KATNAL1 MCM10 TRIM29 TIAM2 AMOT IMMT FLOT2 DCTN2 GSN DUSP16 USP54 | 1.37e-04 | 429 | 231 | 15 | int:DISC1 |
| Interaction | TNIK interactions | SPTAN1 SPTBN1 TIAM2 SYNE2 KIF5B DNM1 HOMER1 DCTN2 NTRK2 ROR2 GSN TJP1 SUPT16H UNC13A | 1.37e-04 | 381 | 231 | 14 | int:TNIK |
| Interaction | PDE4B interactions | 1.39e-04 | 69 | 231 | 6 | int:PDE4B | |
| Interaction | GJA1 interactions | MYH6 MYH7 SPTAN1 SPTBN1 SLC38A1 STX5 NF2 SYNE2 GOLGB1 ARAP2 FLOT2 ROR2 APOB FAM171B SLC3A2 IARS2 TJP1 PHACTR4 | 1.43e-04 | 583 | 231 | 18 | int:GJA1 |
| Interaction | TNIP1 interactions | MYH10 MYH11 RSL1D1 SPTAN1 SPTBN1 TNIP3 MCM3 UPF3B MCM10 NF2 GNL2 KIF5B FLOT2 KRT8 CCDC121 APOB TMEM43 CPS1 THOC2 GSN SLC3A2 ARHGAP5 CCDC59 MYH14 DUSP16 SUPT16H EIF3B RPL5 FTSJ3 | 1.51e-04 | 1217 | 231 | 29 | int:TNIP1 |
| Interaction | PDZRN3 interactions | 1.77e-04 | 46 | 231 | 5 | int:PDZRN3 | |
| Interaction | PARD3 interactions | TIAM2 NF2 AMOT FLOT2 NTRK2 ROR2 FAM171B SLC3A2 RND3 TJP1 PHACTR4 USP54 | 1.78e-04 | 298 | 231 | 12 | int:PARD3 |
| Interaction | HDAC6 interactions | MYH10 MYH11 ABCF3 RSL1D1 SPTAN1 SPTBN1 MCM3 CLIP1 PELO SPOP IMMT GOLGB1 FLOT2 KRT7 KRT8 CPS1 GSN SLC3A2 MYH14 TJP1 ATM RPL5 EP300 FTSJ3 | 1.79e-04 | 929 | 231 | 24 | int:HDAC6 |
| Interaction | TMPO interactions | MYH10 STAG1 ATRX SPTAN1 MCM3 ADARB1 STX5 NF2 SYNE2 IMMT MTUS2 RTN4 APOB SLC3A2 RND3 MYH14 CLMN CDK5RAP2 EIF3B RPL5 EP300 | 1.95e-04 | 762 | 231 | 21 | int:TMPO |
| Interaction | DLG5 interactions | 2.02e-04 | 176 | 231 | 9 | int:DLG5 | |
| Interaction | EBAG9 interactions | STX2 SPTAN1 COG3 SLC38A1 STX5 GOLGB1 FLOT2 ROR2 FAM171B SLC3A2 PHACTR4 CUX1 | 2.08e-04 | 303 | 231 | 12 | int:EBAG9 |
| Interaction | HOMER1 interactions | 2.15e-04 | 140 | 231 | 8 | int:HOMER1 | |
| Interaction | OCLN interactions | SPTAN1 SPTBN1 SLC38A1 NF2 GOLGB1 ARAP2 FLOT2 ANKFY1 NTRK2 ROR2 FAM171B SLC3A2 RND3 TJP1 PHACTR4 USP54 | 2.25e-04 | 500 | 231 | 16 | int:OCLN |
| Interaction | LHX5 interactions | 2.29e-04 | 11 | 231 | 3 | int:LHX5 | |
| Interaction | ANKRD20A1 interactions | 2.29e-04 | 11 | 231 | 3 | int:ANKRD20A1 | |
| Interaction | CEP152 interactions | 2.30e-04 | 179 | 231 | 9 | int:CEP152 | |
| Interaction | SYNGAP1 interactions | MAP2 ARHGAP26 SPTBN1 SYNE2 DNM1 DHX29 HOMER1 DOCK1 RTN4 FAAP100 EIF3B ULK2 | 2.34e-04 | 307 | 231 | 12 | int:SYNGAP1 |
| Interaction | YWHAZ interactions | TET2 MYH10 MYH11 MAP2 MYO9A SPTAN1 SPTBN1 MTMR1 CLIP1 LYST FSIP2 STOX2 SYNE2 SPOP KIF5B HOMER1 ARAP2 KRT8 ROR2 CAMSAP3 GSN TJP1 DUSP16 PHACTR4 IRAG2 CDK5RAP2 ATM USP54 RPL5 EP300 | 2.59e-04 | 1319 | 231 | 30 | int:YWHAZ |
| Interaction | C11orf52 interactions | EPS8 SPTAN1 SPTBN1 SLC38A1 NF2 AMOT ARAP2 FLOT2 ROR2 FAM171B SLC3A2 PHACTR4 | 2.63e-04 | 311 | 231 | 12 | int:C11orf52 |
| Interaction | LZTR1 interactions | 2.94e-04 | 111 | 231 | 7 | int:LZTR1 | |
| Interaction | ACTB interactions | CPNE2 TET2 EPS8 MAP9 MYH10 MYH11 MAP2 SPTAN1 SPTBN1 MTMR1 ADARB1 FSIP2 AMOT DNM1 HSD17B4 HOMER1 HTR1E DCTN2 OTUB1 LCP1 GSN TRAP1 TJP1 CLMN PHACTR4 EP300 | 3.02e-04 | 1083 | 231 | 26 | int:ACTB |
| GeneFamily | Myosin heavy chains | 1.14e-13 | 15 | 150 | 8 | 1098 | |
| GeneFamily | Keratins, type II | 6.88e-05 | 27 | 150 | 4 | 609 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD20A2P ANKRD20A3P NUDT12 ANKRD20A4P ANKRD20A1 ARAP2 ANKFY1 ANKRD23 IBTK | 1.92e-04 | 242 | 150 | 9 | 403 |
| GeneFamily | Cytochrome P450 family 11 | 2.04e-04 | 3 | 150 | 2 | 1007 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 9.72e-04 | 53 | 150 | 4 | 103 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.40e-03 | 7 | 150 | 2 | 1113 | |
| GeneFamily | Adenosine deaminases acting on RNA | 1.85e-03 | 8 | 150 | 2 | 1303 | |
| GeneFamily | MCM family | 2.37e-03 | 9 | 150 | 2 | 1085 | |
| GeneFamily | Copines | 2.37e-03 | 9 | 150 | 2 | 829 | |
| GeneFamily | Cytochrome P450 family 4 | 3.27e-03 | 36 | 150 | 3 | 1003 | |
| GeneFamily | LIM class homeoboxes | 4.27e-03 | 12 | 150 | 2 | 522 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.42e-03 | 40 | 150 | 3 | 321 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | CPNE2 EPS8 MYH6 ADARB1 CLIP1 FCHSD2 KIF5B ALDH1A3 UBE2Q2 ARAP2 DOCK1 TMEM43 | 5.17e-06 | 265 | 234 | 12 | M1684 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | CPNE2 EPS8 MYH6 ADARB1 CLIP1 FCHSD2 KIF5B ALDH1A3 UBE2Q2 ARAP2 DOCK1 TMEM43 | 6.73e-06 | 272 | 234 | 12 | MM1027 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYH10 MYO9A MGAT4A C1GALT1 CLIP1 NUDT12 STOX2 BBX SYNE2 ASPM KIF5B DHX29 MNAT1 GOLGB1 DEPDC1 ARHGAP5 CCDC59 CDK5RAP2 ATM | 7.72e-06 | 656 | 234 | 19 | M18979 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | MYH10 SPTAN1 SPTBN1 TUBGCP5 CLIP1 KIF5B CNTRL GSN ARHGAP5 CDK5RAP2 | 1.30e-05 | 199 | 234 | 10 | M5893 |
| Coexpression | GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP | TET2 MYH11 ARHGAP26 MGAT4A FCHSD2 TRIM36 FLT1 CDV3 DUSP16 KCNIP4 | 1.36e-05 | 200 | 234 | 10 | M9856 |
| Coexpression | CHICAS_RB1_TARGETS_SENESCENT | CPNE2 MYH10 ATRX MCM3 CLIP1 NSD3 IRF9 BBX ALDH1A3 MMP9 DNM1 FLT1 POSTN MCUR1 CDK5RAP2 HADH CDC6 | 1.45e-05 | 565 | 234 | 17 | M2125 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ATRX MAP2 MGAT4A NAP1L2 KATNAL1 CLIP1 LYST KMT2C BBX SYNE2 KIF5B MTUS2 GOLGB1 CDV3 SPOPL RTN4 GSN ARHGAP5 GTF3C1 MYH14 RALGPS1 HADH RPL5 | 1.47e-05 | 946 | 234 | 23 | M39169 |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_DN | 3.49e-05 | 101 | 234 | 7 | M1514 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.68e-05 | 180 | 234 | 9 | M8239 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | MYO9A SPTBN1 FAM161B CLIP1 TIAM2 TPCN1 SH3YL1 BBX SYNE2 GOLGB1 KRT7 KRT8 CCDC80 GSN FMNL3 ARHGAP5 L3MBTL1 CLMN USP54 CCDC152 | 4.15e-05 | 807 | 234 | 20 | M16651 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ATRX MAP2 MYT1 ADGRB1 NAP1L2 ACVR2B CLIP1 LYST SLC38A1 FSIP2 STOX2 LSM11 DNM1 MTUS2 UBE2Q2 PDE11A ENOX1 RTN4 FAM171B EFHC2 LHX1 RALGPS1 KCNIP4 UNC13A | 5.86e-05 | 1106 | 234 | 24 | M39071 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_UP | ATRX MTMR1 ANKRD20A3P ANKRD20A8P ST14 ANKRD20A4P VPS35L UBE2Q2 ANKRD20A1 | 6.07e-05 | 192 | 234 | 9 | MM752 |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_DN | 7.69e-05 | 198 | 234 | 9 | M9407 | |
| Coexpression | GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 8.30e-05 | 200 | 234 | 9 | M7613 | |
| Coexpression | YAGI_AML_WITH_INV_16_TRANSLOCATION | MYH11 DHX38 FKTN HSD17B4 MNAT1 IMMT MTUS2 FLT1 SFSWAP OTUB1 APOB CPS1 THOC2 | 9.11e-05 | 411 | 234 | 13 | M1047 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | POP4 ATRX RSL1D1 SPTBN1 MGAT4A MTMR1 SSX4 CLIP1 SLC38A1 SYNE2 SPOP ARAP2 FLOT2 ANKFY1 SFSWAP CNTRL REST THOC2 MFN1 IBTK CCDC59 SCUBE3 EIF3B ATM HADH | 9.51e-05 | 1215 | 234 | 25 | M41122 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | MYH10 ATRX MAP2 RSL1D1 ARHGAP26 MYT1 CLIP1 TMEM132C FCHSD2 BBX USP38 SYNE2 GNL2 LHX5 GOLGB1 ARAP2 KRT7 CDV3 ENOX1 CAMSAP3 LCP1 LHX1 ARHGAP5 MYH14 CDK5RAP2 CFAP74 CYP4F3 | 9.23e-06 | 989 | 229 | 27 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 9.47e-06 | 69 | 229 | 7 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | POP4 ATRX DHX38 FCHSD2 BBX ASPM GNL2 KIF5B HOMER1 UBE2Q2 DOCK1 DEPDC1 MYH14 TJP1 SUPT16H CFAP74 FTSJ3 | 1.45e-05 | 469 | 229 | 17 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CYP4F8 MYH10 POP4 ATRX SWT1 RSL1D1 C1GALT1 UPF3B MCM10 ACVR2B CLIP1 FKTN SYNE2 CCDC138 ASPM GNL2 HOMER1 CNTRL DEPDC1 FAM171B THOC2 POLR3F ARHGAP5 IARS2 L3MBTL1 MYH14 SUPT16H CFAP74 ATM CUX1 FTSJ3 | 1.46e-05 | 1257 | 229 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | CPNE2 CYP4F8 ATRX MAP2 SWT1 RSL1D1 UPF3B KATNAL1 MCM10 TRIM29 CLIP1 SH2D4B NUDT12 STOX2 SYNE2 CCDC138 ASPM HOMER1 NTRK2 CNTRL DEPDC1 FAM171B RND3 LHX1 ARHGAP5 IARS2 MYH14 SUPT16H CFAP74 ATM CFAP61 ULK2 FTSJ3 | 2.30e-05 | 1414 | 229 | 33 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.58e-05 | 110 | 229 | 8 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CYP4F8 ATRX SWT1 RSL1D1 UPF3B KATNAL1 MCM10 CLIP1 SH2D4B NUDT12 STOX2 SYNE2 CCDC138 ASPM HOMER1 CNTRL DEPDC1 FAM171B RND3 ARHGAP5 IARS2 MYH14 SUPT16H CFAP74 ATM ULK2 FTSJ3 | 3.13e-05 | 1060 | 229 | 27 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500 | MYH11 VPS33A NAP1L2 MCM3 NSD3 TMEM132C STOX2 NF2 MMP9 CAVIN2 FLT1 FAM171B RND3 HADH CUX1 | 5.52e-05 | 420 | 229 | 15 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ADAD1 RBM44 SWT1 MYO9A SPTAN1 MGAT4A MCM10 SOHLH2 BBX AMOT CCDC138 POLR3F LHX1 IARS2 TRAP1 EIF3B ATM CFAP61 RPL5 SLC25A31 CCDC152 FTSJ3 | 7.03e-05 | 810 | 229 | 22 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TET2 MYH10 POP4 ATRX MAP2 SWT1 RSL1D1 ARHGAP26 C1GALT1 UPF3B MCM10 CLIP1 NSD3 FCHSD2 SYNE2 ASPM GNL2 DNM1 HOMER1 CNTRL ROR2 DEPDC1 THOC2 ARHGAP5 IARS2 MYH14 SUPT16H ATM CFAP61 | 8.63e-05 | 1252 | 229 | 29 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CYP4F8 MYH10 POP4 ATRX MAP2 SWT1 RSL1D1 C1GALT1 UPF3B MCM10 ACVR2B CLIP1 FKTN SYNE2 CCDC138 ASPM GNL2 HOMER1 CNTRL DEPDC1 FAM171B THOC2 POLR3F ARHGAP5 IARS2 L3MBTL1 MYH14 SUPT16H CFAP74 ATM CUX1 FTSJ3 | 1.01e-04 | 1459 | 229 | 32 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CPNE2 ATRX MAP2 RSL1D1 MYT1 CLIP1 STOX2 SYNE2 ASPM LHX5 DYNC2H1 NTRK2 CAMSAP3 LHX1 SUPT16H CFAP74 | 1.08e-04 | 498 | 229 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | ADAD1 RBM44 ATRX MYO9A ARHGAP26 SPTBN1 MCM3 ADARB1 NSD3 KMT2C SOHLH2 BBX SYNE2 IMMT LRRIQ3 ANKFY1 SFSWAP THOC2 ARHGAP5 ATM SLC25A31 | 1.09e-04 | 776 | 229 | 21 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | ATRX SPTBN1 MCM3 NSD3 TMEM132C KMT2C SYNE2 ASPM ALDH1A3 IMMT CAVIN2 ANKFY1 SFSWAP REST FAM171B THOC2 GSN POLR3F LHX1 ARHGAP5 CLMN | 1.39e-04 | 790 | 229 | 21 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500 | MYH7 MGAT4A CLIP1 ST14 NF2 ASPM ALDH1A3 DOCK1 KRT8 CNTRL LHX1 IBTK SCUBE3 CUX1 | 1.41e-04 | 406 | 229 | 14 | gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | MYH3 MYH7 MYH11 ACVR2B TRIM29 TMEM132C NF2 DNM1 IMMT DOCK1 KRT8 ROR2 FAM171B CUX1 | 1.45e-04 | 407 | 229 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | CPNE2 ATRX MAP2 MYT1 MGAT4A MTMR1 UPF3B CLIP1 PPP1R26 SLC38A1 STOX2 SYNE2 ASPM LHX5 DYNC2H1 NTRK2 CAMSAP3 FAM171B RND3 TJP1 RALGPS1 SUPT16H CYP4F3 ATM | 1.76e-04 | 986 | 229 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CPNE2 ATRX MAP2 RSL1D1 MYT1 UPF3B MCM10 CLIP1 SLC38A1 STOX2 SYNE2 ASPM LHX5 CDV3 DYNC2H1 NTRK2 CAMSAP3 LHX1 SUPT16H SCUBE3 CFAP74 CDC6 CUX1 IPMK | 1.84e-04 | 989 | 229 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.88e-04 | 185 | 229 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | MYH11 NAP1L2 CLIP1 STOX2 NF2 ASPM MMP9 IMMT CAVIN2 DOCK1 KRT8 FLT1 PDCD6IP CCDC80 CPB1 DEPDC1 RND3 IBTK MCM9 SUPT16H CUX1 | 1.99e-04 | 811 | 229 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | MAP9 MYH3 ATRX MAP2 VPS33A NAP1L2 TMEM132C NF2 ASPM ALDH1A3 IMMT ARAP2 DOCK1 PDCD6IP NTRK2 FAM171B RND3 IBTK MCM9 KCNIP4 CUX1 | 2.23e-04 | 818 | 229 | 21 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | ATRX SPTBN1 NSD3 TMEM132C SYNE2 ASPM IMMT ANKFY1 SFSWAP NTRK2 CLMN | 2.51e-04 | 281 | 229 | 11 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 2.99e-04 | 156 | 229 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | MYH7 MGAT4A C8orf48 TRIM29 ST14 NSD3 KIF5B UBE2Q2 ARAP2 KRT7 KRT8 ROR2 CAMSAP3 LCP1 GSN MYH14 CLMN KCNIP4 HADH CUX1 | 3.21e-04 | 780 | 229 | 20 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#2_top-relative-expression-ranked_100 | 3.27e-04 | 13 | 229 | 3 | gudmap_developingGonad_e14.5_ ovary_100_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 3.41e-04 | 56 | 229 | 5 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_200 | 3.55e-04 | 160 | 229 | 8 | gudmap_developingKidney_e15.5_Medullary collecting duct_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | ATRX SPTBN1 TMEM132C SYNE2 ASPM IMMT ANKFY1 SFSWAP FAM171B GSN | 3.91e-04 | 249 | 229 | 10 | gudmap_developingGonad_P2_epididymis_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | EPS8 MYH3 MYH10 ATRX ARHGAP26 MYT1 TIAM2 IRF9 GNL2 PCDH15 LHX5 ALDH1A3 MTUS2 GOLGB1 KRT7 CDV3 GSN POSTN LHX1 MYH14 CFAP74 CYP4F3 ULK2 | 3.98e-04 | 979 | 229 | 23 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_500 | 4.02e-04 | 58 | 229 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k4 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.02e-04 | 58 | 229 | 5 | gudmap_kidney_P0_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | CPNE2 UPF3B CLIP1 STOX2 SYNE2 ASPM DYNC2H1 NTRK2 FAM171B TJP1 SUPT16H | 4.14e-04 | 298 | 229 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | RBM44 ATRX MCM3 STOX2 SOHLH2 SYNE2 ASPM IMMT SFSWAP REST THOC2 LHX1 SLC25A31 | 4.60e-04 | 403 | 229 | 13 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | MYH6 RBM44 ATRX SPTBN1 MCM3 NSD3 STOX2 SOHLH2 BBX SYNE2 ASPM IMMT ANKFY1 SFSWAP REST THOC2 POLR3F LHX1 CLMN SLC25A31 | 4.86e-04 | 806 | 229 | 20 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | MYH11 ATRX MGAT4A VPS33A NAP1L2 TRIM29 TMEM132C NF2 ASPM ARAP2 DOCK1 KRT8 ROR2 CPB1 FAM171B OGN IBTK SUPT16H KCNIP4 CUX1 | 4.86e-04 | 806 | 229 | 20 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.32e-04 | 259 | 229 | 10 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | MYH11 TNIP3 COL6A5 ST14 STOX2 TBATA KRT7 KRT8 APOA4 EFCAB3 RND3 TJP1 DUSP16 | 5.53e-04 | 411 | 229 | 13 | GSM854302_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | ATRX SPTBN1 NAP1L2 MCM3 NSD3 SYNE2 ASPM IMMT ANKFY1 SFSWAP DEPDC1 REST FAM171B THOC2 RND3 LHX1 CLMN CDC6 SLC25A31 FTSJ3 | 5.59e-04 | 815 | 229 | 20 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-08 | 176 | 236 | 10 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | COL6A5 TMEM132C TBATA PCDH15 NTRK2 CCDC80 FAM171B OGN GSN POSTN | 7.22e-08 | 189 | 236 | 10 | 4f9608b84d135268a17455661870c46ae8554a24 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATRX SPTBN1 SYNE2 KIF5B GOLGB1 CDV3 CNTRL APOB ARHGAP5 CYB5R4 | 7.97e-08 | 191 | 236 | 10 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P SLC38A1 ANKRD20A4P CLIC2 MTUS2 ANKRD20A1 ENOX1 ARHGAP5 | 7.97e-08 | 191 | 236 | 10 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATRX SPTBN1 SYNE2 KIF5B GOLGB1 CDV3 CNTRL APOB ARHGAP5 CYB5R4 | 7.97e-08 | 191 | 236 | 10 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P CLIC2 MTUS2 ANKRD20A1 FLT1 ENOX1 ARHGAP5 | 8.37e-08 | 192 | 236 | 10 | bd3d00b094d92463b06023361a71240851a542b8 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYH10 COL6A5 ADARB1 TMEM132C PCDH15 ALDH1A3 ROR2 CCDC80 OGN RND3 | 8.37e-08 | 192 | 236 | 10 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | STX2 SPTAN1 SPTBN1 MGAT4A NSD3 SH3YL1 SLC38A1 SYNE2 ARHGAP5 DUSP16 | 8.79e-08 | 193 | 236 | 10 | 194b49c152e3e3f599068ec88a7f0af6427b743a |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYH10 MAP2 ARHGAP26 SPTAN1 DNM1 HOMER1 MTUS2 NTRK2 KCNIP4 UNC13A | 1.12e-07 | 198 | 236 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | SAMD9 ATRX C1GALT1 NSD3 SYNE2 DHX29 GOLGB1 ATP5F1EP2 REST THOC2 | 1.17e-07 | 199 | 236 | 10 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | SAMD9 SPTAN1 SPTBN1 CHI3L2 LYST SYNE2 ARAP2 CNTRL OGN DUSP16 | 1.17e-07 | 199 | 236 | 10 | f307d4887b28cf60a591439e278fd668409cb104 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.23e-07 | 200 | 236 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-07 | 178 | 236 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P SLC38A1 ANKRD20A4P CLIC2 MTUS2 ANKRD20A1 ARHGAP5 | 6.36e-07 | 184 | 236 | 9 | c6affa0b12510363258f65e46bf2d47bf4a8e75f |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P CLIC2 MTUS2 ANKRD20A1 ENOX1 ARHGAP5 | 6.36e-07 | 184 | 236 | 9 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.28e-07 | 187 | 236 | 9 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P SLC38A1 ANKRD20A4P CLIC2 MTUS2 ANKRD20A1 ENOX1 | 7.61e-07 | 188 | 236 | 9 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.96e-07 | 189 | 236 | 9 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.96e-07 | 189 | 236 | 9 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | ARHGAP26 SPTBN1 TMEM132C PCDH15 ANO2 FLT1 POSTN ZNF804B KCNIP4 | 7.96e-07 | 189 | 236 | 9 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | ARHGAP26 SPTBN1 TMEM132C FCHSD2 PCDH15 ANO2 FLT1 POSTN KCNIP4 | 7.96e-07 | 189 | 236 | 9 | c81787a8c662db5d7814c583dd64562857629e81 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYH10 COL6A5 ADARB1 TMEM132C PCDH15 ALDH1A3 ROR2 CCDC80 RND3 | 8.32e-07 | 190 | 236 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.69e-07 | 191 | 236 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-07 | 191 | 236 | 9 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.07e-07 | 192 | 236 | 9 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.07e-07 | 192 | 236 | 9 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-07 | 194 | 236 | 9 | 592e8c4b73ba424a52305ac411ea9c0a2dc44467 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.12e-06 | 197 | 236 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-06 | 198 | 236 | 9 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.17e-06 | 198 | 236 | 9 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.17e-06 | 198 | 236 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.22e-06 | 199 | 236 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | NS-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.22e-06 | 199 | 236 | 9 | d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 200 | 236 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-06 | 200 | 236 | 9 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 200 | 236 | 9 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-06 | 200 | 236 | 9 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-06 | 200 | 236 | 9 | b75154417c215b8853186bff46d624ebd387ac4f | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.27e-06 | 200 | 236 | 9 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.27e-06 | 200 | 236 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.27e-06 | 200 | 236 | 9 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-dn_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.27e-06 | 200 | 236 | 9 | d01aa5fccada22f97d8350ad5888df2aadb5bb1c | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.27e-06 | 200 | 236 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-06 | 200 | 236 | 9 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-06 | 167 | 236 | 8 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 4.27e-06 | 174 | 236 | 8 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-06 | 177 | 236 | 8 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 4.84e-06 | 177 | 236 | 8 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 5.94e-06 | 182 | 236 | 8 | 84018a84e1aa52fa52ccfc26db9cd1fb6d535b31 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.70e-06 | 185 | 236 | 8 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.70e-06 | 185 | 236 | 8 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.70e-06 | 185 | 236 | 8 | d42dcc92a34fcdabf112565fbd5fd26cbd4de58a | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P CLIC2 MTUS2 ANKRD20A1 ARHGAP5 | 6.97e-06 | 186 | 236 | 8 | b05c394aa3573ba855abc3066739ca193883b0c3 |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 186 | 236 | 8 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-06 | 190 | 236 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 192 | 236 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 192 | 236 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.78e-06 | 192 | 236 | 8 | 7ab626a516b07d899175ff12f1c8257688324e4b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 192 | 236 | 8 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.12e-06 | 193 | 236 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 193 | 236 | 8 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.12e-06 | 193 | 236 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-06 | 194 | 236 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 9.47e-06 | 194 | 236 | 8 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.47e-06 | 194 | 236 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.47e-06 | 194 | 236 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.47e-06 | 194 | 236 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 195 | 236 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 196 | 236 | 8 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.06e-05 | 197 | 236 | 8 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.06e-05 | 197 | 236 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | MGAT4A ANKRD20A2P ANKRD20A3P ANKRD20A4P PCDH15 ANO2 FLT1 NTRK2 | 1.06e-05 | 197 | 236 | 8 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.06e-05 | 197 | 236 | 8 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | COVID-19_Severe-dn_T|COVID-19_Severe / Disease condition and Cell class | 1.09e-05 | 142 | 236 | 7 | 2008033881b9e1b20926c3508d6ebdb6f1a1528f | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.10e-05 | 198 | 236 | 8 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 198 | 236 | 8 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ANKRD20A2P ANKRD20A3P ANKRD20A4P CLIC2 MTUS2 ENOX1 LCP1 IRAG2 | 1.10e-05 | 198 | 236 | 8 | fa5c15a656d4132950092919600e270f1fd79abf |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | ANKRD20A2P ANKRD20A3P ANKRD20A4P CLIC2 ANKRD20A1 ENOX1 FAM171B GSN | 1.10e-05 | 198 | 236 | 8 | da84c76afe835aeee39da04b63c03549218b5d91 |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 198 | 236 | 8 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | ANKRD20A2P ANKRD20A3P ANKRD20A4P CLIC2 ANKRD20A1 ENOX1 FAM171B GSN | 1.10e-05 | 198 | 236 | 8 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.10e-05 | 198 | 236 | 8 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | critical-Epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.14e-05 | 199 | 236 | 8 | bbb44e2a52f102a6d891ead6c06d6c07221abd33 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.14e-05 | 199 | 236 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-05 | 199 | 236 | 8 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | critical-Lymphoid-NKT-proliferating|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.14e-05 | 199 | 236 | 8 | 9284956d852e434a91be892e88e06a7c71f8c583 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-05 | 199 | 236 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-dn_T|ICU-NoSEP / Disease, condition lineage and cell class | 1.14e-05 | 199 | 236 | 8 | 7fb211f803a8b3a2cfa9455386abea08131c6b52 | |
| ToppCell | NS-moderate-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-05 | 199 | 236 | 8 | aa2b51940115c22768c0d7493b4b60d41df3f376 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.14e-05 | 199 | 236 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-05 | 199 | 236 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-05 | 199 | 236 | 8 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | NS-critical-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-05 | 199 | 236 | 8 | 3b68197ec01c5f2b315d9e9b6eb02d5f6b5b77a3 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.14e-05 | 199 | 236 | 8 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.14e-05 | 199 | 236 | 8 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 236 | 8 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.18e-05 | 200 | 236 | 8 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 1.18e-05 | 200 | 236 | 8 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| Drug | purealin | 3.83e-10 | 58 | 235 | 10 | CID006419303 | |
| Drug | formycin triphosphate | 2.38e-09 | 51 | 235 | 9 | CID000122274 | |
| Drug | fast white | 2.26e-07 | 42 | 235 | 7 | CID000024008 | |
| Drug | N-ethylmaleimide | STX2 MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 PLPP5 MYO9A SPTAN1 SPTBN1 STX5 KIF5B DNM1 IMMT GOLGB1 SLC3A2 GTF3C1 MYH14 | 3.97e-07 | 511 | 235 | 20 | CID000004362 |
| Drug | 2bq7 | 6.14e-07 | 123 | 235 | 10 | CID006540267 | |
| Drug | NSC107658 | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MYO9A SPTAN1 AMOT MMP9 DCTN2 LCP1 GSN MYH14 | 7.53e-07 | 306 | 235 | 15 | CID000002919 |
| Drug | MgCl2 | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 POP4 MYO9A SPTAN1 SPTBN1 DNAH9 GSN IARS2 MYH14 HADH | 9.38e-07 | 354 | 235 | 16 | CID000024584 |
| Drug | S-(-)-Etomoxir | 9.60e-07 | 100 | 235 | 9 | CID000060765 | |
| Drug | AC1NRBPQ | 1.65e-06 | 137 | 235 | 10 | CID005288569 | |
| Drug | NSC339663 | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MYO9A SYNE2 IMMT DOCK1 GSN MYH14 | 2.18e-06 | 250 | 235 | 13 | CID000003892 |
| Drug | blebbistatin | 3.34e-06 | 116 | 235 | 9 | CID003476986 | |
| Drug | B0683 | 3.58e-06 | 117 | 235 | 9 | CID006398969 | |
| Drug | AC1L1IZ2 | ATP5F1E MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MYO9A DNAH9 CPS1 GSN GTF3C1 MYH14 | 3.67e-06 | 304 | 235 | 14 | CID000004795 |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 5.89e-06 | 194 | 235 | 11 | 1060_UP | |
| Drug | bromfenacoum | MYH10 MYH11 ATRX SPTAN1 SPTBN1 PCYT2 IMMT MTUS2 FLOT2 CDV3 PDCD6IP RTN4 CAMSAP3 PRKRA IARS2 TRAP1 MYH14 TJP1 CLMN RPL5 | 1.31e-05 | 644 | 235 | 20 | ctd:C013418 |
| Drug | clenbuterol | 1.73e-05 | 142 | 235 | 9 | CID000002783 | |
| Drug | candesartan cilexetil | 2.05e-05 | 145 | 235 | 9 | CID000002540 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.48e-05 | 186 | 235 | 10 | 3279_DN | |
| Drug | SM-2 | 3.31e-05 | 87 | 235 | 7 | CID000486033 | |
| Drug | NSC9700 | MYH2 MYH3 MYH4 MYH6 MYH7 CYP4F8 MYH10 MYH11 CYP11B1 CYP11B2 CLIP1 HSD17B4 UGT1A9 CYP4F2 TEX13A LCP1 CYP4F3 ATM | 3.45e-05 | 578 | 235 | 18 | CID000005408 |
| Drug | trifluoperazine | MYH2 MYH3 MYH4 MYH6 MYH7 MYH10 MYH11 MAP2 MYO9A SPTAN1 SPTBN1 UGT1A9 MYH14 | 3.50e-05 | 324 | 235 | 13 | CID000005566 |
| Drug | oxovanadium | 3.56e-05 | 120 | 235 | 8 | CID000024411 | |
| Drug | carvedilol | 4.68e-05 | 161 | 235 | 9 | CID000002585 | |
| Drug | AC1O5PIQ | 4.85e-05 | 39 | 235 | 5 | CID006438348 | |
| Drug | 4-chloroaniline | 5.01e-05 | 202 | 235 | 10 | CID000007812 | |
| Drug | Clorgyline | 6.51e-05 | 168 | 235 | 9 | ctd:D003010 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 5.63e-09 | 10 | 222 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 5.63e-09 | 10 | 222 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 5.63e-09 | 10 | 222 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 5.63e-09 | 10 | 222 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 5.63e-09 | 10 | 222 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 5.63e-09 | 10 | 222 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 5.63e-09 | 10 | 222 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 5.63e-09 | 10 | 222 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.75e-08 | 12 | 222 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.75e-08 | 12 | 222 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.82e-08 | 13 | 222 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 6.51e-08 | 15 | 222 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | MYH7 CYP4F8 CYP11B1 CYP11B2 MMP9 HSD17B4 ATG7 CYP4F2 CPS1 POSTN EP300 | 1.33e-06 | 227 | 222 | 11 | DOID:10763 (biomarker_via_orthology) |
| Disease | myopathy (implicated_via_orthology) | 1.60e-06 | 48 | 222 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 8.05e-06 | 63 | 222 | 6 | EFO_0001645, EFO_0004792 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.44e-05 | 7 | 222 | 3 | C0751337 | |
| Disease | protocadherin alpha-7 measurement | 1.44e-05 | 7 | 222 | 3 | EFO_0801973 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.61e-05 | 71 | 222 | 6 | EFO_0001645, EFO_0004791 | |
| Disease | Malignant neoplasm of breast | SPTAN1 COG3 TRIM29 CLIP1 STX5 NF2 FKTN SYNE2 MMP9 DNAH9 GOLGB1 KRT8 FLT1 DYNC2H1 VPS39 UGT1A9 GSN ATM USP54 CYB5R4 EP300 CUX1 | 2.26e-05 | 1074 | 222 | 22 | C0006142 |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.03e-05 | 160 | 222 | 8 | DOID:5844 (biomarker_via_orthology) | |
| Disease | von Willebrand factor measurement, coronary artery disease | 3.23e-05 | 118 | 222 | 7 | EFO_0001645, EFO_0004629 | |
| Disease | protein FAM163B measurement | 3.41e-05 | 9 | 222 | 3 | EFO_0802936 | |
| Disease | apolipoprotein L1 measurement | 3.48e-05 | 25 | 222 | 4 | EFO_0021854 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 4.85e-05 | 10 | 222 | 3 | DOID:7693 (is_marker_for) | |
| Disease | triglycerides in medium HDL measurement | 5.40e-05 | 54 | 222 | 5 | EFO_0022321 | |
| Disease | Glucocorticoid-remediable aldosteronism | 5.64e-05 | 2 | 222 | 2 | C1260386 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 5.64e-05 | 2 | 222 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | mitochondrial complex V (ATP synthase) deficiency nuclear type 3 (implicated_via_orthology) | 5.64e-05 | 2 | 222 | 2 | DOID:0060332 (implicated_via_orthology) | |
| Disease | protein FAM171B measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0801947 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 6.63e-05 | 11 | 222 | 3 | EFO_0801461 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 6.63e-05 | 11 | 222 | 3 | EFO_0021862 | |
| Disease | stomach cancer (is_marker_for) | 1.04e-04 | 142 | 222 | 7 | DOID:10534 (is_marker_for) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.35e-04 | 148 | 222 | 7 | C0279702 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.52e-04 | 67 | 222 | 5 | C3463824 | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 1.68e-04 | 3 | 222 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | low density lipoprotein triglyceride measurement | 1.79e-04 | 15 | 222 | 3 | EFO_0009946 | |
| Disease | coronary artery disease, factor VII measurement | 1.99e-04 | 111 | 222 | 6 | EFO_0001645, EFO_0004619 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.00e-04 | 71 | 222 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | factor VIII measurement, coronary artery disease | 2.19e-04 | 113 | 222 | 6 | EFO_0001645, EFO_0004630 | |
| Disease | glioblastoma (is_marker_for) | 3.34e-04 | 44 | 222 | 4 | DOID:3068 (is_marker_for) | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 3.35e-04 | 4 | 222 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 3.35e-04 | 4 | 222 | 2 | cv:C3495498 | |
| Disease | Caveolinopathy | 3.35e-04 | 4 | 222 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 3.35e-04 | 4 | 222 | 2 | 192600 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.35e-04 | 4 | 222 | 2 | cv:CN293514 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.50e-04 | 80 | 222 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 3.52e-04 | 173 | 222 | 7 | C0023467 | |
| Disease | triacylglycerol 54:4 measurement | 3.97e-04 | 46 | 222 | 4 | EFO_0010422 | |
| Disease | Renal Cell Carcinoma | 4.29e-04 | 128 | 222 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.29e-04 | 128 | 222 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.29e-04 | 128 | 222 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.29e-04 | 128 | 222 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.29e-04 | 128 | 222 | 6 | C1306837 | |
| Disease | Cardiomyopathy | 4.32e-04 | 47 | 222 | 4 | cv:C0878544 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 5.55e-04 | 5 | 222 | 2 | C0410190 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 5.55e-04 | 5 | 222 | 2 | C1450051 | |
| Disease | 3-hydroxyanthranilate 3;4-dioxygenase measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0021997 | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 5.55e-04 | 5 | 222 | 2 | DOID:446 (is_implicated_in) | |
| Disease | level of carboxypeptidase N subunit 2 in blood serum | 5.55e-04 | 5 | 222 | 2 | OBA_2041122 | |
| Disease | cholesterol to total lipids in small HDL percentage | 5.91e-04 | 51 | 222 | 4 | EFO_0022240 | |
| Disease | triglycerides in HDL measurement | 6.84e-04 | 53 | 222 | 4 | EFO_0022317 | |
| Disease | Bladder Neoplasm | 6.88e-04 | 140 | 222 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 7.14e-04 | 141 | 222 | 6 | C0005684 | |
| Disease | West Syndrome | 7.57e-04 | 24 | 222 | 3 | C0037769 | |
| Disease | glioblastoma (is_implicated_in) | 7.57e-04 | 24 | 222 | 3 | DOID:3068 (is_implicated_in) | |
| Disease | cholesteryl ester 18:1 measurement | 7.57e-04 | 24 | 222 | 3 | EFO_0010344 | |
| Disease | triglycerides in very large HDL measurement | 7.87e-04 | 55 | 222 | 4 | EFO_0022324 | |
| Disease | Emery-Dreifuss muscular dystrophy | 8.29e-04 | 6 | 222 | 2 | cv:C0410189 | |
| Disease | Conn Syndrome | 8.29e-04 | 6 | 222 | 2 | C1384514 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 8.29e-04 | 6 | 222 | 2 | C0410189 | |
| Disease | X-11423--O-sulfo-L-tyrosine measurement | 8.29e-04 | 6 | 222 | 2 | EFO_0021231 | |
| Disease | Hyperaldosteronism | 8.29e-04 | 6 | 222 | 2 | C0020428 | |
| Disease | response to calcium channel blocker | 8.43e-04 | 56 | 222 | 4 | EFO_0007767 | |
| Disease | complement factor H-related protein 1 measurement | 8.43e-04 | 56 | 222 | 4 | EFO_0600054 | |
| Disease | triglycerides in LDL measurement | 8.43e-04 | 56 | 222 | 4 | EFO_0022320 | |
| Disease | Limb-girdle muscular dystrophy | 9.61e-04 | 26 | 222 | 3 | cv:C0686353 | |
| Disease | pre-eclampsia (is_marker_for) | 9.63e-04 | 58 | 222 | 4 | DOID:10591 (is_marker_for) | |
| Disease | Adenoid Cystic Carcinoma | 9.72e-04 | 100 | 222 | 5 | C0010606 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 1.09e-03 | 60 | 222 | 4 | EFO_0021898 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.13e-03 | 154 | 222 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | cardiomyopathy (is_marker_for) | 1.15e-03 | 7 | 222 | 2 | DOID:0050700 (is_marker_for) | |
| Disease | Obstructive asymmetric septal hypertrophy | 1.15e-03 | 7 | 222 | 2 | C0597124 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 1.15e-03 | 7 | 222 | 2 | C0700053 | |
| Disease | leucine-rich repeat-containing protein 15 measurement | 1.15e-03 | 7 | 222 | 2 | EFO_0801761 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.20e-03 | 28 | 222 | 3 | DOID:8634 (is_marker_for) | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 1.24e-03 | 62 | 222 | 4 | EFO_0022263 | |
| Disease | familial hyperlipidemia | 1.26e-03 | 106 | 222 | 5 | MONDO_0001336 | |
| Disease | Hematopoetic Myelodysplasia | 1.33e-03 | 29 | 222 | 3 | C2713368 | |
| Disease | myocardial infarction | 1.41e-03 | 350 | 222 | 9 | EFO_0000612 | |
| Disease | response to angiotensin receptor blocker | 1.47e-03 | 30 | 222 | 3 | EFO_0010735 | |
| Disease | Primary familial dilated cardiomyopathy | 1.47e-03 | 30 | 222 | 3 | cv:C0340427 | |
| Disease | microcephaly (is_implicated_in) | 1.53e-03 | 8 | 222 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | tyrosine-protein kinase JAK2 measurement | 1.53e-03 | 8 | 222 | 2 | EFO_0020825 | |
| Disease | factor XI measurement, coronary artery disease | 1.81e-03 | 115 | 222 | 5 | EFO_0001645, EFO_0004694 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.81e-03 | 169 | 222 | 6 | DOID:3908 (is_marker_for) | |
| Disease | Heart Failure, Diastolic | 1.94e-03 | 33 | 222 | 3 | C1135196 | |
| Disease | Situs ambiguous | 1.96e-03 | 9 | 222 | 2 | C1167664 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 1.96e-03 | 9 | 222 | 2 | C0949658 | |
| Disease | ceramide measurement | 2.10e-03 | 235 | 222 | 7 | EFO_0010222 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.10e-03 | 301 | 222 | 8 | DOID:684 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AKEFVKLKSDTRSAE | 1681 | Q9UPW8 | |
| FNALKDKFRKTRDSL | 671 | Q5TYW2 | |
| EERKKFESLKSDFNK | 166 | Q8NFU0 | |
| SFKQRLVLKSSLAKE | 11 | O43315 | |
| KRKEKKTADLSQAAF | 146 | Q86W67 | |
| LKKSARTRKENKFSA | 1276 | Q09472 | |
| EDTRKTISQLFAKNK | 531 | Q4VCS5 | |
| KKLLDTEQRKFLASD | 706 | Q8NHU2 | |
| TKNAVEKFTDAKRSL | 1456 | Q7Z7A1 | |
| FEQKDRLSQSKASKE | 731 | P55884 | |
| FRNAAKETLAKAVLA | 511 | Q96FN4 | |
| FNALKDKFRKTRDSL | 671 | Q5CZ79 | |
| KKKLERFNSTRFNLD | 56 | Q86SG2 | |
| FEKSAKENLRDSKEL | 356 | Q8WY36 | |
| FKKLDSELSRAQEKA | 1326 | O14514 | |
| ALSKRSKEAEAAFLN | 66 | P39880 | |
| FNALKDKFRKTRDSL | 671 | Q4UJ75 | |
| KIADSKRAFELQKSA | 211 | Q14254 | |
| STVNAKKLEKAEARL | 116 | Q9NUQ8 | |
| SFNEDFKLAFKKLIR | 346 | P28566 | |
| AAVFTKNLDKALKLA | 441 | P47895 | |
| SRKLDAVAIEAKFKQ | 556 | A6QL63 | |
| NKKESRSNAAKLALD | 146 | Q96M93 | |
| ELLESFKKDARSFKL | 1161 | Q8WZ64 | |
| FQKDFTKSTKERLLL | 166 | Q15782 | |
| IKTSQADFNKTKLER | 1071 | Q8IYA2 | |
| SDQIKKEKSLLVDFF | 936 | Q9NQ90 | |
| KAVRDALKTEFKANA | 21 | P56381 | |
| DKFSQAAKVAELEKR | 216 | Q13561 | |
| LLDAKEQAATFKLEK | 271 | Q7Z478 | |
| KAQALKLAAKRFIFE | 176 | Q6ZUS5 | |
| SFAERKKQLVKAEAE | 566 | Q9P1Y5 | |
| ERSLDNFFAKRDKKK | 6 | Q9UKY7 | |
| AKAQKQFRLFKTAAL | 1911 | Q8IZT6 | |
| KVVRDALKTEFKANA | 21 | Q5VTU8 | |
| KEDKKQSLENFLSRF | 761 | Q76M96 | |
| IEKLSAAFAKAREAL | 341 | Q96SN8 | |
| FFRKNESALVKEKEL | 1036 | Q5JR59 | |
| VKDDDLSKVAAFRAK | 271 | Q13613 | |
| LAFTKNSDAKIAVKE | 871 | Q6ZP01 | |
| KKLQTRAANLESKFL | 116 | Q9ULW6 | |
| ALLNRKDKTTFEKLD | 161 | Q5JS13 | |
| QKEARSLSTELFKLK | 1471 | P12883 | |
| KLFVQDLATRVKKSA | 801 | P33176 | |
| KTLNNKFASFIDKVR | 96 | P05787 | |
| FFVSAKEVLSARKQK | 281 | Q8IWA4 | |
| FNALKDKFRKTRDSL | 671 | Q5SQ80 | |
| KKNAEELKARISASA | 246 | P06727 | |
| RAELALSAFLKQKKT | 206 | Q96LL4 | |
| TFKNNKSAEAILKRE | 846 | Q9P2R3 | |
| DALNKFSDNTLKLLK | 81 | Q9UM21 | |
| KLDSVFEERLSKKLF | 566 | P14780 | |
| ESSRKNAKEALAVKA | 1041 | Q13127 | |
| LDKAKAKKFSAVRIS | 611 | Q13823 | |
| RKSFKDLTLLNKDSR | 4211 | Q8NEZ4 | |
| FDRLKLQDSSKKEAD | 226 | P83369 | |
| KSEFSALRAENEKIK | 236 | Q96AQ8 | |
| KVRTDTKLDFNLEKS | 266 | Q96AQ8 | |
| SQKAIIFKRLSKDAV | 181 | Q8N7X4 | |
| KRKNKQAFLDELESS | 176 | P51948 | |
| KKAAKREEALASFEA | 461 | Q49MG5 | |
| KTLNNKFASFIDKVR | 96 | P08729 | |
| SKSFRDFLLEEKKSV | 1201 | Q9P2D0 | |
| KDITAALAAERKFFL | 246 | Q05193 | |
| VKNELFKRLDKFAAE | 126 | Q16836 | |
| KRTAAENEFVTLKKD | 296 | P12035 | |
| EASREDSSFLQKLKK | 3401 | Q5CZC0 | |
| ANSLIREFKKSDIKV | 5316 | Q5CZC0 | |
| RESSFKKDDKLFQLS | 5616 | Q5CZC0 | |
| KSNILRFFAKLVTDK | 431 | Q5JST6 | |
| STLEKKQRKFDQLLA | 1461 | Q7Z406 | |
| QKKEAKELAFLEAAR | 361 | Q99447 | |
| SDKINRALAAAKKDN | 301 | Q8WUM4 | |
| LKSTDVAKTFRKAIN | 81 | P13796 | |
| LKAELSDSEASARKK | 656 | Q9Y468 | |
| FIDSKKASEKLLASI | 741 | Q9UKX2 | |
| AALDKKQRNFDKILA | 1446 | Q9UKX2 | |
| ASQKELRKSFARSKA | 116 | Q9HCR9 | |
| FSAAAKVAKTRKENV | 1236 | Q6ZU69 | |
| EALELLEAQSKFTKK | 71 | Q6PIL6 | |
| SKDKDSIFKLRNLSR | 131 | Q5TB30 | |
| ARFNKIKKLTAKDFA | 126 | P20774 | |
| KQKLEEKRAFDSAVA | 436 | Q16891 | |
| DLAATAEAKISKQKA | 276 | Q96MY7 | |
| TIKAKQLETLKAAFA | 186 | P48742 | |
| TIKAKQLETLKAAFA | 186 | Q9H2C1 | |
| RLSISFENVDTAKKK | 776 | Q96RT8 | |
| KKLSAKRADLQSTFS | 421 | Q7L590 | |
| KKLAKARAAQSALAA | 281 | P78563 | |
| FLKKAVDQRNKALTS | 471 | Q0VG06 | |
| DKAAIRKELNEFKSS | 671 | Q8IZ21 | |
| FKEAARLAKEKSQEK | 106 | Q86YM7 | |
| TKLNDRTLAEKFLSK | 266 | Q8NFU5 | |
| DVFKFNSSKLRVNKL | 281 | P35240 | |
| VAAEALKATSAFLRK | 431 | Q5TIA1 | |
| SLRNKDIKEAFRKAT | 306 | Q8NGQ1 | |
| KFSKTRSKDIFDQLA | 286 | P25205 | |
| KVELSESRLKAFKVA | 736 | P25205 | |
| KLKSARKFTFLSDED | 1506 | Q96QU1 | |
| DDSKELQRFKAVSAK | 106 | Q96FW1 | |
| LQRFKAVSAKSKEDL | 111 | Q96FW1 | |
| AKKLDKENLSDERAS | 301 | Q9BZI7 | |
| RSDTNLTKLKFKEDD | 151 | Q8NCM8 | |
| KDAKVLSRKLVAIFN | 1836 | Q8NCM8 | |
| KSSEFENKQALLKRA | 2406 | Q13315 | |
| FNALKDKFRKTRDSL | 671 | Q5VUR7 | |
| AKKKAEKRLFDASSF | 6 | Q9H0C2 | |
| ALLKKTKNSEEFAAA | 111 | P04114 | |
| FIDDAVKKLNELSFK | 2396 | P04114 | |
| LSDIAEKFLKKDQSD | 961 | P46100 | |
| KLFAEAVQKSRKVDS | 1471 | P31327 | |
| FKTADKKLLLEQAAN | 96 | O95352 | |
| KNKETKRLRSSFDAL | 261 | Q96M89 | |
| SFDALKELNDTLKKQ | 271 | Q96M89 | |
| RSSQDSKDKSEKIFA | 516 | Q14185 | |
| SLDLKKTRDAAFKIL | 636 | Q96JB2 | |
| NDVSRFKAIKARFAK | 551 | P51659 | |
| KAASKVTLLEANRAK | 631 | Q8IVF7 | |
| SRNIAKDEFKAVKAL | 1971 | A8TX70 | |
| FRARKLDDKDLFSKS | 236 | Q9UBL6 | |
| EDSNKLKRSFSLDIK | 391 | Q9BY84 | |
| EIEKFKAENASLAKL | 916 | Q9HC77 | |
| FLQAKAKSKTLDFID | 286 | P98187 | |
| EFDAKLARVQTKSKS | 186 | Q4G0S7 | |
| VDAVARDFSQALKKK | 161 | P15538 | |
| SKEDFDSLLQSAKKK | 286 | P08195 | |
| AIAKQASFSSKSRDK | 281 | Q5T1N1 | |
| RALNKAKNSSDAKLE | 21 | Q99741 | |
| FNLSKSTRKKLADKF | 221 | Q9BRF8 | |
| FLQAKAKSKTLDFID | 286 | P78329 | |
| VAFRKSAKELLQLAA | 271 | O75072 | |
| SLFQRLDSKSKDISK | 2871 | Q99698 | |
| KLEKSIKFLSQCAAR | 276 | Q12912 | |
| KTRLRCALNKSSEFK | 81 | Q00978 | |
| SKEALKRFVDAFKTD | 216 | Q9NS00 | |
| DTAKEDAANRKLAKL | 286 | P06396 | |
| VDAVARDFSQALKKK | 161 | P19099 | |
| FLQAKAKSKTLDFID | 286 | Q08477 | |
| KLQKAAEAFSELSKR | 286 | Q12929 | |
| NLAKLTARFEKATAD | 3316 | Q9NYC9 | |
| TARFEKATADKLKCQ | 3321 | Q9NYC9 | |
| LSRFSTSFLDEKKKQ | 176 | A6NE01 | |
| REKADIEAKSKLSLF | 166 | O94868 | |
| LKKVDSLKKAFSRQN | 236 | O95810 | |
| SDFIKVLTDKNLFLK | 106 | Q8N7B9 | |
| KAVKALKASAEFQLN | 51 | Q92681 | |
| VLSIKQRASFKIKDA | 476 | Q8IX30 | |
| AALLAEKLKDDSKFS | 266 | Q8TC92 | |
| KETKALADFIRNKLS | 281 | P15086 | |
| DKLKKKTAEDRTQAF | 61 | Q9C0B2 | |
| KVALKAEDKSQLFNA | 416 | Q6P995 | |
| KKFDQLLAEEKSISA | 1451 | P35580 | |
| KENSLEAIRSKLDKA | 706 | P30622 | |
| ANKNFEKSLLKEFKR | 131 | O15247 | |
| LSAVATDLRKDKAKS | 226 | P61587 | |
| SLRNKEFKSALCKIV | 291 | Q6IF99 | |
| ESNKKKRLALDSEAA | 816 | Q9NXL9 | |
| TDKEARKKVLKQAFS | 46 | Q6NUM9 | |
| SSEKAKDSFNEKRVA | 361 | Q9NQC3 | |
| FELALKKIAKSVSAA | 461 | Q9BW62 | |
| FEALIKKDLQAKESA | 251 | Q9C093 | |
| AAAREKLAQASKESK | 661 | Q12872 | |
| KDRIKSFTTNEKAIL | 296 | Q14134 | |
| IDSSKKLRLDKFQTQ | 321 | Q9NQ86 | |
| LIDKVDNFKSLSLSK | 196 | Q9BTV4 | |
| LVKKVKLDAFSSADL | 6 | Q9BWW7 | |
| NSSVDLFILRAKVKK | 316 | Q8N3T6 | |
| IKASNKSRAAEIDDK | 5981 | Q8WXH0 | |
| AFKADFKTLAESRKA | 361 | Q5K651 | |
| FKTLAESRKAAEEKF | 366 | Q5K651 | |
| ESRKAAEEKFRAKTN | 371 | Q5K651 | |
| KNLSSAKRKFADSLN | 51 | Q9UNA1 | |
| SEAKKAAKILREFTE | 11 | Q96HL8 | |
| SSKKAKRDLIDNSFN | 676 | Q8IY81 | |
| QLRSSERSAKKFKAK | 201 | O95707 | |
| KKDRVAQKKASFLRA | 276 | P46777 | |
| KKELKELASRVAFLT | 146 | Q96M53 | |
| LRKEKKAQTSLESQF | 71 | Q9P031 | |
| KESRSLSTELFKVKN | 1476 | Q9Y623 | |
| AALDKKQRNFDKVLA | 1441 | P11055 | |
| FSKTLLDRKSEKRNN | 121 | Q9BQG2 | |
| VKTDNKLLLENRSKF | 226 | Q9BRX2 | |
| IRKFLAEKAKESVSS | 841 | Q5T8A7 | |
| KFLQSKAETARESKQ | 186 | Q9H1D9 | |
| RKKARSFAKAAIEKQ | 181 | Q9NSE4 | |
| IKRAAASKLQSAEKL | 116 | Q13017 | |
| KQAKLKEISLSAVRF | 461 | Q01974 | |
| RKANKAVDFTTVKFL | 656 | Q5T5J6 | |
| AAALDKKQRNFDKIL | 1441 | P13533 | |
| SEFLKRNLDKSKVLV | 476 | Q7L1T6 | |
| LIREKNESNKSSFDK | 106 | Q9Y5B9 | |
| KASEKRSKAFDDIAT | 16 | Q16384 | |
| NKIRAKLKAIEQSFD | 86 | P32856 | |
| KALADEREAVQKKTF | 46 | Q01082 | |
| TILAKRKSLFDDKAV | 116 | Q13190 | |
| DFKSKNVLLKSDLTA | 321 | Q13705 | |
| NIAKALKFLEDSNVK | 96 | Q96JQ2 | |
| SKKKLQDFASTVEAL | 1376 | P35749 | |
| KFKSTIAALEAKIAQ | 1811 | P35749 | |
| VKTLKDASDNARKDF | 571 | Q16620 | |
| LKAELKFLASIFDKN | 6 | Q8WVN8 | |
| KKSTAKALEDVKANF | 41 | A4D1E1 | |
| NTKKSSQRLKDALLD | 721 | Q8NI27 | |
| KTLAKDEALKRQSSL | 876 | Q7Z3J2 | |
| KVAELKTKLDAAERF | 71 | Q96KP6 | |
| ERAKTDKAFKAFLDA | 1216 | Q8IVF5 | |
| ESVKLLFVKTEKSAA | 246 | O76021 | |
| QISEKLRKAFDDIAK | 16 | O60224 | |
| KASEKRSKAFDDIAK | 16 | Q7RTT6 | |
| FRLSFKKDKTKQLAN | 271 | Q9P2F5 | |
| KASEKRSKAFNDIAT | 16 | Q7RTT4 | |
| SEVRAKFKFSLLNAK | 96 | Q6IQ16 | |
| KFKFSLLNAKREETK | 101 | Q6IQ16 | |
| SEVRAKFKFSILNAK | 96 | O43791 | |
| ALFKANRLEKAVAAA | 151 | Q92791 | |
| FQKDLKANESRLKDI | 1136 | Q13813 | |
| TEFVSLASKVKDALK | 111 | Q9Y5Y6 | |
| LIFLAKFLKKADTRD | 71 | Q8NEB5 | |
| KFLKKADTRDSRQAC | 76 | Q8NEB5 | |
| KKVIKSASQDRFSLE | 871 | Q8TBZ2 | |
| VLSEFSSKLLRQDKK | 1006 | Q8WVM7 | |
| SSEFAKKKSILEQRQ | 516 | Q92620 | |
| ESLTKKAKRFLANLV | 306 | Q8IYK8 | |
| FSNCRSLFKDKKLVE | 121 | O60656 | |
| VDFTDLSENLAKKLK | 811 | Q8NB14 | |
| TSINKTFKKALEEAA | 1031 | Q9BZ95 | |
| LSKEFDQEKKANDRL | 946 | P11137 | |
| SKKQAKRNAAEKFLA | 176 | O75569 | |
| FKNSSKLVAAAEKER | 211 | Q8NEG5 | |
| FENKRSASLETKKDV | 1271 | Q07157 | |
| DTFNDIEKRKFKSLL | 321 | Q9ULQ1 | |
| KKLTEKLNRFFSDKQ | 936 | Q8IYT8 | |
| RLIKFFIDQSKKDAE | 421 | Q12931 | |
| KSAAQALASDLKKLR | 101 | Q9BXU3 | |
| EITKKFRDALANEKA | 121 | Q5SQS7 | |
| LSKKAKIISAAFEER | 311 | Q96AX1 | |
| EKLKQDKRFSTFLSL | 501 | Q15063 | |
| VEKLKEKFSSALRNS | 1371 | Q12789 | |
| ASLSEFEKNKKISLL | 191 | Q9NX45 | |
| LKSKRDLFFLNKDAA | 921 | P17948 | |
| AKKAAAEKLSSLENS | 1471 | Q6N021 | |
| RSSLFELAKKTKFNL | 376 | Q9H2H9 | |
| LVAFLSKNRDKNFLK | 341 | Q9H1B5 | |
| SNFKKALNRFEKLVE | 16 | B1ANS9 | |
| RFEVTLEKSNKNFSK | 61 | Q96JC1 | |
| ESLNIDSIFSKDKRK | 581 | Q70EL1 | |
| KIKARLKAEFEALES | 26 | Q9NQZ6 | |
| LSAVTATQKKKAERF | 176 | A6NN73 | |
| KKAQAELASFKVLLD | 2071 | Q14789 | |
| KRTAAENEFVLLKKD | 226 | Q3SY84 | |
| KALFLKEKSQKASER | 501 | A6PVS8 | |
| DRKATDDTTLLAFKK | 1511 | Q6PIF6 | |
| KDISSLEFAENKAKT | 2256 | B2RTY4 | |
| ANLAKELEKFSKVTF | 571 | Q01538 |